Commission Implementing Regulation (EU) 2025/243 of 30 January 2025 amending Annex I to Implementing Regulation (EU) 2021/403 as regards model animal health certificates for movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof
Date: 2025-01-30
Institutions: Directorate-General for Health and Food Safety, European Commission
Subjects: animal health, animal product, embryo and foetus, health certificate, intra-EU transport, live animal, livestock, transport of animals, veterinary inspection








L_202500243EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2025/243


7.2.2025







            COMMISSION IMPLEMENTING REGULATION (EU) 2025/243
of 30 January 2025
         
amending Annex I to Implementing Regulation (EU) 2021/403 as regards model animal health certificates for movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof
(Text with EEA relevance)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (1), and in particular Articles 146(2) and 162(5) thereof,


Having regard to Regulation (EU) 2017/625 of the European Parliament and of the Council of 15 March 2017 on official controls and other official activities performed to ensure the application of food and feed law, rules on animal health and welfare, plant health and plant protection products, amending Regulations (EC) No 999/2001, (EC) No 396/2005, (EC) No 1069/2009, (EC) No 1107/2009, (EU) No 1151/2012, (EU) No 652/2014, (EU) 2016/429 and (EU) 2016/2031 of the European Parliament and of the Council, Council Regulations (EC) No 1/2005 and (EC) No 1099/2009 and Council Directives 98/58/EC, 1999/74/EC, 2007/43/EC, 2008/119/EC and 2008/120/EC and repealing Regulations (EC) No 854/2004 and (EC) No 882/2004 of the European Parliament and of the Council, Council Directives 89/608/EEC, 89/662/EEC, 90/425/EEC, 91/496/EEC, 96/23/EC, 96/93/EC and 97/78/EC and Council Decision 92/438/EEC (Official Controls Regulation) (2), and in particular Article 90, first paragraph, point (a), thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2021/403 (3) establishes model certificates, in the form of animal health certificates, animal health/official certificates and declarations for, among others, movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof. Those consignments include those falling within the scope of Commission Delegated Regulation (EU) 2020/688 (4).












(2)


Chapters 1 (model ‘BOV-INTRA-X’), 5 (model ‘OV/CAP-INTRA-X’), 9 (model ‘CAM-INTRA-X’), 11 (model ‘CER-INTRA-X’) and 13 (model ‘OTHER-UNGULATES-INTRA-X’) of Annex I to Implementing Regulation (EU) 2021/403 set out model animal health certificates for movements between Member States of certain categories of ungulates susceptible to infection with epizootic haemorrhagic disease virus (EHDV). The amendments to Articles 10, 15, 23, 26 and 29 of Delegated Regulation (EU) 2020/688 by Commission Delegated Regulation (EU) 2024/3160 (5) concerning additional requirements related to infection with EHDV should be reflected in those model certificates accordingly.












(3)


Chapters 30 (model ‘OV/CAP-SEM-A-INTRA’) and 33 (model ‘OV/CAP-OOCYTES-EMB-A-INTRA) of Annex I to Implementing Regulation (EU) 2021/403 set out model animal health certificates for movements between Member States of semen, oocytes and embryos of ovine and caprine animals collected or produced after 20 April 2021. The amendments to Chapter A, Section A, points 4.2(d) and (e), of Annex VIII to Regulation (EC) 999/2001 of the European Parliament and of the Council (6) by Commission Regulation (EU) 2024/887 (7) concerning caprine animals genetically resistant to classical scrapie strains should be reflected in point II.1.2.4 and point II.2 of those model certificates accordingly.












(4)


In the interests of clarity and consistency of Union rules, the model certificates set out in Chapters 1, 5, 9, 11, 13, 30 and 33 of Annex I to Implementing Regulation (EU) 2021/403 should be updated, including an update of notes and structural elements, when incorporating the amendments described in the preceding recitals. Those model certificates should therefore be replaced by the updated model certificates set out in the Annex to this Regulation.












(5)


Annex I to Implementing Regulation (EU) 2021/403 should therefore be amended accordingly.












(6)


The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,





HAS ADOPTED THIS REGULATION:



Article 1
Annex I to Implementing Regulation (EU) 2021/403 is amended in accordance with the Annex to this Regulation.


Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.




This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 30 January 2025.


For the Commission


The President

Ursula VON DER LEYEN
            





(1)  
            OJ L 84, 31.3.2016, p. 1, ELI: http://data.europa.eu/eli/reg/2016/429/oj.

(2)  
            OJ L 95, 7.4.2017, p. 1, ELI: http://data.europa.eu/eli/reg/2017/625/oj.

(3)  Commission Implementing Regulation (EU) 2021/403 of 24 March 2021 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates and model animal health/official certificates, for the entry into the Union and movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof, official certification regarding such certificates and repealing Decision 2010/470/EU (OJ L 113, 31.3.2021, p. 1, ELI: http://data.europa.eu/eli/reg_impl/2021/403/oj).

(4)  Commission Delegated Regulation (EU) 2020/688 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council, as regards animal health requirements for movements within the Union of terrestrial animals and hatching eggs (OJ L 174, 3.6.2020, p. 140, ELI: http://data.europa.eu/eli/reg_del/2020/688/oj).

(5)  Commission Delegated Regulation (EU) 2024/3160 of 9 October 2024 amending Delegated Regulation (EU) 2020/688 as regards certain animal health requirements for movements within the Union of terrestrial animals (OJ L, 2024/3160, 20.12.2024, ELI: http://data.europa.eu/eli/reg_del/2024/3160/oj).

(6)  Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (OJ L 147, 31.5.2001, p. 1, ELI: http://data.europa.eu/eli/reg/2001/999/oj).

(7)  Commission Regulation (EU) 2024/887 of 22 March 2024 amending Annexes IV, VIII, and IX to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards animal feeding, placing on the market and importation into the Union (OJ L, 2024/887, 25.3.2024, ELI: http://data.europa.eu/eli/reg/2024/887/oj).




ANNEX
Annex I to Implementing Regulation (EU) 2021/403 is amended as follows:






(1)


Chapter 1 is replaced by the following:

                                 ‘CHAPTER 1

MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF BOVINE ANIMALS NOT INTENDED FOR SLAUGHTER (MODEL “BOV-INTRA-X”)


Part I:   Description of consignment








EUROPEAN UNION




INTRA




















I.1




Consignor



 



I.2




IMSOC reference



 


 




 


Name


 



I.2a




Local reference



 


 




 


Address


 



I.3




Central Competent Authority



 



QR CODE





 


 




 


Country


ISO country code



I.4




Local Competent Authority



 


 





I.5




Consignee



 



I.6




Operator conducting assembly operations independently of an establishment





 


Name


 


 


Name


Registration No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.7




Country of origin



ISO country code



I.9




Country of destination



ISO country code





I.8




Region of origin



Code



I.10




Region of destination



Code





I.11




Place of dispatch



 



I.12




Place of destination



 




 


Name


Registration/Approval No


 


Name


Registration/Approval No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.13




Place of loading




I.14




Date and time of departure



















I.15




Means of transport



 



I.16




Transporter





 


☐ Vessel


☐ Aircraft


 


Name


Registration/Authorisation No




 


Address


 




 


☐ Railway


☐ Road vehicle


 


Country


ISO country code





I.17




Accompanying documents





 


Identification


☐ Other


 


Type


Code




 


Document


 


Country


ISO country code




 


Commercial document reference


 

















I.18




Transport conditions



☐ Ambient


☐ Chilled


☐ Frozen





I.19




Container number/Seal number





 


Container No


Seal No


 

















I.20




Certified as or for





☐ Further keeping


☐ Slaughter


☐ Confined establishment


☐ Germinal products




☐ Registered equine animal


☐ Travelling circus/animal act


☐ Exhibition


☐ Event or activity near borders




☐ Release into the wild


☐ Dispatch centre


☐ Relaying area/purification centre


☐ Ornamental aquaculture establishment




☐ Further processing


☐ Organic fertilizers and soil improvers


☐ Technical use


☐ Quarantine or similar establishment




☐ Products for human consumption


☐ Pollination


☐ Live aquatic animals for human consumption


☐ Other















I.21




☐ For transit through a third country





 


Third country


ISO country code




 


Exit point


BCP code




 


Entry point


BCP code


















I.22




☐ For transit through Member State(s)




I.23




☐ For export





 


Member State


ISO country code


 


Third country


ISO country code




 


Member State


ISO country code


 


Exit point


BCP code




 


Member State


ISO country code


 


 


 


















I.24




Estimated journey time




I.25




Journey log



☐ yes


☐ no





I.26




Total number of packages




I.27




Total quantity






I.28




Total net weight/gross weight (kg)




I.29




Total space foreseen for the consignment






















I.30




Description of consignment





CN code


Species


Subspecies/Category


Sex


Identification system


Identification number


Age


Quantity




 


 


 


 


 


 


 


Type




Region of origin


 


Cold store


 


Identification mark


Type of packaging


 


Net weight




 


 


 


 


 


 


 


 




Slaughterhouse


 


Treatment type


 


Nature of commodity


Number of packages


 


Batch No




 


 


 


 


 


 


 


 




 


 


Date of collection/production


 


Manufacturing plant


Approval or registration number of plant/establishment/centre


Test


 





Part II:   Certification












EUROPEAN UNION




Certificate model BOV-INTRA-X





 



II. Health information




II.a




Certificate reference




II.b




IMSOC reference










I, the undersigned official veterinarian, hereby certify that:






II.1.


The bovine animals (1) of the consignment described in Part I meet the following requirements:






II.1.1.


They are identified as provided for in Article 38 of Commission Delegated Regulation (EU) 2019/2035.










II.1.2.


They, for at least 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age:






II.1.2.1.


have been continuously resident in the establishment of origin;










II.1.2.2.


have not been in contact with kept bovine animals of a lower health status or subject to movement restrictions for animal health reasons;










II.1.2.3.


have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the last 30 days prior to the date of departure of the animals.














II.1.3.


They have not shown clinical signs or symptoms of diseases listed for bovine animals during the clinical examination which was carried out, within the last 24 hours prior to the time of departure of the consignment, on … (insert date dd/mm/yyyy).














II.2.


According to official information, the animals described in Part I meet the following health requirements:






II.2.1.









(2)
either



[They come from establishments or zones not subject to movement restrictions affecting bovine animals and established for reasons of diseases listed for those species or diseases subject to emergency measures relevant for those species, and they have not been in contact with kept animals of a listed species of a lower health status for an adequate period.]











(2)
or



[They come from establishments or zones subject to movement restrictions affecting bovine animals and established for … (3), but derogations from movement restrictions have been granted, and:











(2)



[they comply with the requirements set out in …(4);]]











(2)



[and in particular, they are … (5).]]














II.2.2.


They come from establishments free from infection with Brucella abortus, B. melitensis and B. suis without vaccination regarding bovine animals, and:











(2)
either



[the establishments of origin are situated in a Member State or zone thereof with the status free from infection with Brucella abortus, B. melitensis and B. suis regarding the bovine population;]











(2)
and/or



[they have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on a sample taken during the last 30 days prior to the date of departure, and in the case of post-parturient females taken at least 30 days after parturition;]











(2)
and/or



[they are less than 12 months old;]











(2)
and/or



[they are castrated.]










II.2.3.


They come from establishments free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), and:











(2)
either



[the establishments of origin are situated in a Member State or zone thereof with the status free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis);]











(2)
and/or



[they have been subjected to a test for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) with one of the diagnostic methods provided for in Part 2 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, during the last 30 days prior to the date of departure of the consignment;]











(2)
and/or



[they are less than 6 weeks old.]










II.2.4.


They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of departure of the consignment.










II.2.5.


They come from establishments situated in an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus:











(2)
either



[has not been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX to Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally disease-free area;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the seasonally disease-free area;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been protected against attacks by vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX to Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been vaccinated against infection with epizootic haemorrhagic disease virus and the animals are within the immunity period guaranteed in the specifications of the vaccine and:







(2)
either



[they have been vaccinated at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[they have been vaccinated with an inactivated vaccine and have been subject to a PCR test, with negative results on samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals comply with specific risk-mitigating measures defined by the competent authority of the Member State of destination and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and



[the requirements laid down in Article 10(1), third subparagraph, of Delegated Regulation (EU) 2020/688 are fulfilled.]










II.2.6.


They come from establishments in which anthrax in ungulates has not been reported during the last 15 days prior to the date of departure of the consignment.










II.2.7.


They come from establishments in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of departure of the consignment, and











(2)
either



[surra has not been reported in the establishments during the last 2 years prior to the date of their departure.]











(2)
or



[surra has been reported during the last 2 years prior to the date of departure of the consignment, and following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments.]















(2)
either









[II.2.8.


They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of departure of the consignment, and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) in the last 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]















(2)
and/or









[II.2.8.


They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:











(2)
either









[II.2.8.1.


have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689:











(2)
either









[II.2.8.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]















(2)
and/or









[II.2.8.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]]



















(2)
and/or









[II.2.8.2.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:











(2)
either









[II.2.8.2.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.2.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.8.2.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.8.3.


have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported in that Member State or zone thereof during the last 2 years prior to the date of departure of the consignment and are within the immunity period guaranteed in the specifications of the vaccine and:











(2)
either









[II.2.8.3.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.3.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]



















(2)
and/or









[II.2.8.4.


have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported in that Member State or zone thereof during the last 2 years prior to the date of departure of the consignment, and:











(2)
either









[II.2.8.4.1.


the serological test has been carried out on samples collected at least 60 days prior to the date of departure of the consignment.]]]















(2)
and/or









[II.2.8.4.2.


the serological test has been carried out on samples collected at least 30 days prior to the date of departure of the consignment and the animals have been subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment.]]]























(2)
and/or









[II.2.8.


They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:











(2)
either









[II.2.8.1.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:











(2)
either









[II.2.8.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.8.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.8.2.


have been kept for the last 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or within an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and:











(2)
either









[II.2.8.2.1.


the animals have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept and are within the immunity period guaranteed in the specifications of the vaccine, and:











(2)
either









[II.2.8.2.1.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.8.2.1.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results on samples collected at least 14 days after the date of onset of the immunity set in the specifications of the vaccine;]]]]



















(2)
and/or









[II.2.8.2.2.


the animals have been immunised against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept, and:











(2)
either









[II.2.8.2.2.1.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.8.2.2.2.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days prior to the date of the departure of the consignment and to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment.]]]]



























(2)
and/or









[II.2.8.


They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof:











(2)
either









[II.2.8.1.


with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:











(2)
either









[II.2.8.1.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.1.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.1.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.1.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]















(2)
and/or









[II.2.8.2.


with an approved eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:











(2)
either









[II.2.8.2.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]]















(2)
and/or









[II.2.8.3.


neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised:











(2)
either









[II.2.8.3.1.


without any conditions, and















(2)
and/or









[II.2.8.3.2.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.3.3.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.3.4.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 7, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.3.5.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 8, of Annex V to Delegated Regulation (EU) 2020/689, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]]



















(2) [(2)
either









[II.2.9.


They are moved to a Member State or zone thereof with the status free from enzootic bovine leukosis, and











(2)
either









[II.2.9.1.


they come from establishments free from enzootic bovine leukosis.]]]















(2)
or









[II.2.9.1.


they come from establishments not free from enzootic bovine leukosis, and enzootic bovine leukosis has not been reported in those establishments during the last 24 months prior to the date of departure of the consignment, and:











(2)
either









[II.2.9.1.1.


they are over 24 months of age and they have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out with negative results:











(2)
either









[II.2.9.1.1.1.


on samples taken on two occasions at an interval of at least 4 months while kept in isolation from the other bovine animals of the establishment;]]]]















(2)
and/or









[II.2.9.1.1.2.


on a sample taken during the last 30 days prior to the date of departure of the consignment, and all bovine animals over 24 months of age kept in the establishment have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of departure of the consignment;]]]]



















(2)
and/or









[II.2.9.1.2.


they are less than 24 months of age and they were born to dams subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of departure of the consignment.]]]























(2)
or









[II.2.9.


They are moved to a Member State or zone thereof with an approved eradication programme for enzootic bovine leukosis, and











(2)
either









[II.2.9.1.


they come from establishments free from enzootic bovine leukosis.]]















(2)
or









[II.2.9.1.


they come from establishments not free from enzootic bovine leukosis, and enzootic bovine leukosis has not been reported in those establishments during the last 24 months prior to the date of departure of the consignment, and:











(2)
either









[II.2.9.1.1.


they are over 24 months of age and they have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out with negative results:











(2)
either









[II.2.9.1.1.1.


on samples taken on two occasions at an interval of at least 4 months while kept in isolation from the other bovine animals of the establishment;]]]]















(2)
and/or









[II.2.9.1.1.2.


on a sample taken during the last 30 days prior to the date of departure of the consignment, and all bovine animals over 24 months of age kept in the establishment have been subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of departure of the consignment;]]]]



















(2)
and/or









[II.2.9.1.2.


they are less than 24 months of age and they were born to dams, subjected to a serological test for enzootic bovine leukosis with one of the diagnostic methods provided for in Part 4 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of departure of the consignment.]]]]























(2) [(2)
either









[II.2.10.


They are moved to a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have not been vaccinated against infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and











(2)
either









[II.2.10.1.


they come from establishments free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and:











(2)
either









[II.2.10.1.1.


the establishments of origin are situated in a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]]]]















(2)
and/or









[II.2.10.1.2


the animals have been subjected to quarantine for at least 30 days prior to the date of departure of the consignment and have been subjected to a serological test for the detection of antibodies against whole bovine herpes virus-1 (BoHV-1) with one of the diagnostic methods provided for in Part 5 of Annex I to Delegated Regulation (EU) 2020/688, with a negative result, carried out on a sample taken during the last 15 days prior to the date of departure of the consignment.]]]]



















(2)
or









[II.2.10.1.


they come from establishments not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have been kept in an approved quarantine establishment for at least 30 days prior to the date of departure of the consignment and have been subjected to a serological test for the detection of antibodies against whole BoHV-1, with one of the diagnostic methods provided for in Part 5 of Annex I to Delegated Regulation (EU) 2020/688, with a negative result, carried out on a sample taken not less than 21 days after the date of commencement of the quarantine.]]]



















(2)
or









[II.2.10.


They are moved to a Member State or zone thereof with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and











(2)
either









[II.2.10.1.


they come from establishments free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and:











(2)
either









[II.2.10.1.1.


the establishments of origin are situated in a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]]]]















(2)
and/or









[II.2.10.1.2.


the establishments of origin are situated in a Member State or zone thereof with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]]]]















(2)
and/or









[II.2.10.1.3.


the animals have been subjected to quarantine for at least 30 days prior to departure and have been subjected to a serological test for the detection of antibodies against whole bovine herpes virus-1 (BoHV-1) with one of the diagnostic methods provided for in Part 5 of Annex I to Delegated Regulation (EU) 2020/688 with a negative result, carried out on a sample taken during the last 15 days prior to the date of departure of the consignment;]]]]















(2)
and/or









[II.2.10.1.4.


the animals are destined for an establishment which keeps bovine animals for meat production without contact to bovine animals of other establishments, and from which they are directly moved to the slaughterhouse;]]]]



















(2)
or









[II.2.10.1.


they come from establishments not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and:






II.2.10.1.1.


they have been kept in an approved quarantine establishment for at least 30 days prior to the date of departure of the consignment, and










II.2.10.1.2.


they have been subjected to a serological test for the detection of antibodies against whole BoHV-1, with one of the diagnostic methods provided for in Part 5 of Annex I to Delegated Regulation (EU) 2020/688, with a negative result, carried out on a sample taken not less than 21 days after the date of commencement of the quarantine.]]]























(2) [(2)
either









[II.2.11.


They are moved to a Member State or zone thereof with the status free from bovine viral diarrhoea and they have not been vaccinated against bovine viral diarrhoea, and











(2)
either









[II.2.11.1.


they come from establishments free from bovine viral diarrhoea, and:











(2)
either









[II.2.11.1.1.


the establishments of origin are situated in a Member State or zone thereof with the status free from bovine viral diarrhoea;]]]]















(2)
and/or









[II.2.11.1.2.


the establishments of origin have been subjected to a testing regime as referred in Part VI, Chapter 1, Section 2, point 1(c)(ii) or (iii), of Annex IV to Delegated Regulation (EU) 2020/689, carried out, with negative results, within the 4 months period prior to the date of departure of the consignment;]]]]















(2)
and/or









[II.2.11.1.3.


the animals have been tested individually to exclude the presence of bovine viral diarrhoea virus prior to the date of departure of the consignment;]]]]



















(2)
or









[II.2.11.1.


they come from establishments not free from bovine viral diarrhoea and they have been subjected to a test for bovine viral diarrhoea virus antigen or genome with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried out with negative results, and:











(2)
either









[II.2.11.1.1.


they have been kept in an approved quarantine establishment for a period of at least 21 days prior to the date of departure of the consignment, [and in the case of pregnant dams, they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken not less than 21 days after the date of commencement of the quarantine;] (2) ]]















(2)
and/or









[II.2.11.1.2.


they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, with positive results,











(2)
either









[II.2.11.1.2.1.


in the case of non-pregnant dams, carried out on samples taken prior to the date of departure of the consignment;]]]]]















(2)
and/or









[II.2.11.1.2.1.


in the case of pregnant dams, carried out on samples taken before the date of insemination preceding the current gestation.]]]]]



























(2)
or









[II.2.11.


They are moved to a Member State or zone thereof with an approved eradication programme for bovine viral diarrhoea, and:











(2)
either









[II.2.11.1.


they come from establishments free from bovine viral diarrhoea, and:











(2)
either









[II.2.11.1.1.


the establishments of origin are situated in a Member State or zone thereof with the status free from bovine viral diarrhoea;]]]















(2)
and/or









[II.2.11.1.2.


the establishments of origin are situated in a Member State or zone thereof with an approved eradication programme for bovine viral diarrhoea;]]]















(2)
and/or









[II.2.11.1.3.


the establishments of origin have been subjected to a testing regime as referred in Part VI, Chapter 1, Section 2, point 1(c)(ii) or (iii), of Annex IV to Delegated Regulation (EU) 2020/689, carried out, with negative results, within the last 4 months prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.11.1.4.


the animals have been tested individually to exclude the presence of bovine viral diarrhoea virus prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.11.1.5.


the animals are destined for an establishment which keeps bovine animals for meat production separate from bovine animals of other establishments, and from which they are directly moved to the slaughterhouse;]]]



















(2)
and/or









[II.2.11.2.


they come from establishments not free from bovine viral diarrhoea and they have been subjected to a test for bovine viral diarrhoea virus antigen or genome with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried out with negative results, and:











(2)
either









[II.2.11.2.1.


they have been kept in an approved quarantine establishment for a period of at least 21 days prior to the date of departure of the consignment, [and in case of pregnant dams, they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken not less than 21 days after the date of commencement of the quarantine;] (2)]]















(2)
and/or









[II.2.11.2.2.


they have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus with one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, with positive results,











(2)
either









[II.2.11.2.2.1.


in the case of non-pregnant dams, carried out on samples taken prior to the date of departure of the consignment;]]]]]















(2)
and/or









[II.2.11.2.2.1.


in the case of pregnant dams, carried out on samples taken before the date of insemination preceding the current gestation.]]]]]


























II.3.


To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause.










II.4.


Arrangements are made to transport the consignment in accordance with Article 4 of Delegated Regulation (EU) 2020/688.










II.5.


This animal health certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of animals, the period of validity of the certificate may be extended by the duration of the journey by waterway/sea.











(2) (6) [II.6.


Since the date of departure from their establishments of origin and prior to the date of arrival to this establishment approved for assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and











(2)
either



[they come from their establishments of origin.]]











(2)
or



[at least one of the animals of the consignment has undergone one assembly operation in an approved establishment.]]











(2)
or



[at least one of the animals of the consignment has undergone two assembly operations in the approved establishments.]]





Animal welfare attestation

At the time of inspection, the animals covered by this animal health certificate were fit to be transported in accordance with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start on … (insert date)
(7) (8).

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:








Box reference I.11


:


“Place of dispatch”: Indicate an establishment of the origin of the animals in the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429 of the European Parliament and of the Council.




Box reference I.12


:


“Place of destination”: Indicate an establishment of the final destination of the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.




Box reference I.17


:



                                          “Accompanying documents”: In case the animals are dispatched from an establishment approved for assembly operations in the Member State of origin, the reference number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, may be indicated.
In case the animals are dispatched from an establishment approved for assembly operations in the Member State of passage, the reference number(s) of the certificate(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, shall be indicated.




Box reference I.30


:


“Identification number”: Indicate identification codes of the animals in the consignment identified in accordance with Article 38 of Delegated Regulation (EU) 2019/2035.





Part II:








(1)



There may be one or more animals in the consignment.











(2)



Delete if not applicable.











(3)



Insert the name of the disease(s).











(4)



Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements.











(5)



Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 126(1), points (b)(ii) and (iii), of Regulation (EU) 2016/429.











(6)



Applicable in case the consignment is dispatched from the establishment approved for assembly operations.











(7)



In the case where a consignment is grouped in an establishment approved for assembly operations and comprises animals that were loaded on different dates, the date which the journey commenced for the whole consignment is considered to be the earliest date when any part of the consignment left the establishment of origin.











(8)



This statement does not exempt transporters from their obligation in accordance with Union rules in force in particular regarding the fitness to be transported.

















Official veterinarian





Name (in capital letters)


 


Qualification and title


 




Local Control Unit name


 


Local Control Unit code


 




Date


 


 


 




Stamp


 


Signature’


 




;










(2)


Chapter 5 is replaced by the following:

                                 ‘CHAPTER 5

MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF OVINE AND CAPRINE ANIMALS NOT INTENDED FOR SLAUGHTER (MODEL “OV/CAP-INTRA-X”)


Part I:   Description of consignment








EUROPEAN UNION




INTRA




















I.1




Consignor



 



I.2




IMSOC reference



 


 




 


Name


 



I.2a




Local reference



 


 




 


Address


 



I.3




Central Competent Authority



 



QR CODE





 


 




 


Country


ISO country code



I.4




Local Competent Authority



 


 





I.5




Consignee



 



I.6




Operator conducting assembly operations independently of an establishment





 


Name


 


 


Name


Registration No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.7




Country of origin



ISO country code



I.9




Country of destination



ISO country code





I.8




Region of origin



Code



I.10




Region of destination



Code





I.11




Place of dispatch



 



I.12




Place of destination



 




 


Name


Registration/Approval No


 


Name


Registration/Approval No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.13




Place of loading




I.14




Date and time of departure



















I.15




Means of transport



 



I.16




Transporter





 


☐ Vessel


☐ Aircraft


 


Name


Registration/Authorisation No




 


Address


 




 


☐ Railway


☐ Road vehicle


 


Country


ISO country code





I.17




Accompanying documents





 


Identification


☐ Other


 


Type


Code




 


Document


 


Country


ISO country code




 


Commercial document reference


 

















I.18




Transport conditions



☐ Ambient


☐ Chilled


☐ Frozen





I.19




Container number/Seal number





 


Container No


Seal No


 

















I.20




Certified as or for





☐ Further keeping


☐ Slaughter


☐ Confined establishment


☐ Germinal products




☐ Registered equine animal


☐ Travelling circus/animal act


☐ Exhibition


☐ Event or activity near borders




☐ Release into the wild


☐ Dispatch centre


☐ Relaying area/purification centre


☐ Ornamental aquaculture establishment




☐ Further processing


☐ Organic fertilizers and soil improvers


☐ Technical use


☐ Quarantine or similar establishment




☐ Products for human consumption


☐ Pollination


☐ Live aquatic animals for human consumption


☐ Other















I.21




☐ For transit through a third country





 


Third country


ISO country code




 


Exit point


BCP code




 


Entry point


BCP code


















I.22




☐ For transit through Member State(s)




I.23




☐ For export





 


Member State


ISO country code


 


Third country


ISO country code




 


Member State


ISO country code


 


Exit point


BCP code




 


Member State


ISO country code


 


 


 


















I.24




Estimated journey time




I.25




Journey log



☐ yes


☐ no





I.26




Total number of packages




I.27




Total quantity






I.28




Total net weight/gross weight (kg)




I.29




Total space foreseen for the consignment






















I.30




Description of consignment





CN code


Species


Subspecies/Category


Sex


Identification system


Identification number


Age


Quantity




 


 


 


 


 


 


 


Type




Region of origin


 


Cold store


 


Identification mark


Type of packaging


 


Net weight




 


 


 


 


 


 


 


 




Slaughterhouse


 


Treatment type


 


Nature of commodity


Number of packages


 


Batch No




 


 


 


 


 


 


 


 




 


 


Date of collection/production


 


Manufacturing plant


Approval or registration number of plant/establishment/centre


Test


 





Part II:   Certification












EUROPEAN UNION




Certificate model OV/CAP-INTRA-X





 



II. Health information




II.a




Certificate reference




II.b




IMSOC reference










I, the undersigned official veterinarian, hereby certify that:






II.1.


The ovine/caprine animals (1) of the consignment described in Part I meet the following requirements:






II.1.1.


They are identified as provided for in Article 45(2) or (4) or Article 46(1) of Commission Delegated Regulation (EU) 2019/2035.










II.1.2.


They, for at least 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age:






II.1.2.1.


have been continuously resident in the establishment of origin;










II.1.2.2.


have not been in contact with kept ovine or caprine animals of a lower health status or subject to movement restrictions for animal health reasons;










II.1.2.3.


have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the last 30 days prior to the date of departure of the consignment.














II.1.3.


They have not shown clinical signs or symptoms of diseases listed for ovine/caprine animals during the clinical examination which was carried out, within the last 24 hours prior to the time of departure of the consignment, on … (insert date dd/mm/yyyy).














II.2.


According to official information, the animals described in Part I meet the following health requirements:






II.2.1.









(2)
either



[They come from establishments or zones not subject to movement restrictions affecting ovine/caprine animals and established for reasons of diseases listed for those species or diseases subject to emergency measures relevant for those species, and they have not been in contact with kept animals of a listed species of a lower health status for an adequate period.]











(2)
or



[They come from establishments or zones subject to movement restrictions affecting ovine/caprine animals and established for … (3), but derogations from movement restrictions have been granted, and:











(2)



[they comply with the requirements set out in … (4);]]











(2)



[and in particular, they are … (5).]]



















(2)
either









[II.2.2.


They come from establishments free from infection with Brucella abortus, B. melitensis and B. suis without vaccination regarding ovine and caprine animals, and:











(2)
either



[the establishments of origin are situated in a Member State or zone thereof with the status free from infection with Brucella abortus, B. melitensis and B. suis regarding the ovine and caprine population;]]











(2)
and/or



[they have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on a sample taken during the last 30 days prior to the date of departure of the consignment, and in the case of post-parturient females taken at least 30 days after parturition;]]











(2)
and/or



[they are less than 6 months old;]]











(2)
and/or



[they are castrated.]]















(2)
or









[II.2.2.


They come from establishments free from infection with Brucella abortus, B. melitensis and B. suis with vaccination regarding ovine and caprine animals and they are moved to a Member State or zone thereof without the status free from infection with Brucella abortus, B. melitensis and B. suis regarding ovine and caprine animals.]















(2)
either









[II.2.3.


They are kept ovine animals and come from establishments in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported during the last 42 days prior to date of departure of the consignment.]















(2)
and/or









[II.2.3.


They are kept caprine animals and come from establishments in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the caprine animals kept in the establishments during at least 12 months prior to the date of departure of the consignment, as referred to in Article 15(3) of Delegated Regulation (EU) 2020/688.]










II.2.4.


They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of departure of the consignment.










II.2.5.


They come from establishments situated in an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus:











(2)
either



[has not been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX to Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally disease-free area;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the seasonally disease-free area;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been protected against attacks by vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX to Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been vaccinated against infection with epizootic haemorrhagic disease virus and the animals are within the immunity period guaranteed in the specifications of the vaccine and:







(2)
either



[they have been vaccinated at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[they have been vaccinated with an inactivated vaccine and have been subject to a PCR test, with negative results on samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals comply with specific risk-mitigating measures defined by the competent authority of the Member State of destination and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and



[the requirements laid down in Article 15(1), third subparagraph, of Delegated Regulation (EU) 2020/688 are fulfilled.]










II.2.6.


They come from establishments in which anthrax in ungulates has not been reported during the last 15 days prior to the date of departure of the consignment.










II.2.7.


They come from establishments in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of departure of the consignment, and











(2)
either



[surra has not been reported in the establishments during the last 2 years prior to the date of departure of the consignment.]











(2)
or



[surra has been reported during the last 2 years prior to the date of departure of the consignment, following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments.]















(2)









[II.2.8.


They are kept uncastrated male ovine animals, and:






II.2.8.1.


come from establishments in which ovine epididymitis (Brucella ovis) has not been reported during the last 12 months prior to the date of departure of the consignment, and










II.2.8.2.


have been subjected to a serological test for ovine epididymitis (Brucella ovis), carried out, with negative results, on a sample taken during the last 30 days prior to the date of departure of the consignment.]



















(2)
either









[II.2.9.


They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of departure of the consignment and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) within the last 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]















(2)
and/or









[II.2.9.


They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:











(2)
either









[II.2.9.1.


have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689:











(2)
either









[II.2.9.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.9.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]















(2)
and/or









[II.2.9.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]]



















(2)
and/or









[II.2.9.2.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment;











(2)
either









[II.2.9.2.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.9.2.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.9.2.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.9.3.


have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years in that Member State or zone thereof and are within the immunity period guaranteed in the specifications of the vaccine, and:











(2)
either









[II.2.9.3.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.9.3.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]



















(2)
and/or









[II.2.9.4.


have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported during the last 2 years prior to the date of departure of the consignment in that Member State or zone thereof, and:











(2)
either









[II.2.9.4.1.


the serological test has been carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.9.4.2.


the serological test has been carried out on samples collected at least 30 days prior to the date of departure of the consignment and the animals have been subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]]























(2)
and/or









[II.2.9.


They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and:











(2)
either









[II.2.9.1.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:











(2)
either









[II.2.9.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.9.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.9.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.9.2.


have been kept for the last 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or in an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and:











(2)
either









[II.2.9.2.1.


the animals have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept and are within the immunity period guaranteed in the specifications of the vaccine and:











(2)
either









[II.2.9.2.1.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.9.2.1.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]]



















(2)
and/or









[II.2.9.2.2.


the animals have been immunised against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept, and:











(2)
either









[II.2.9.2.2.1.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.9.2.2.2.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days prior to the date of departure of the consignment and to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]]]



























(2)
and/or









[II.2.9.


They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof:











(2)
either









[II.2.9.1.


with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:











(2)
either









[II.2.9.1.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.9.1.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.9.1.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.9.1.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]]















(2)
and/or









[II.2.9.2.


with an approved eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised under the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:











(2)
either









[II.2.9.2.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.9.2.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.9.2.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.9.2.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]]















(2)
and/or









[II.2.9.3.


neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised:











(2)
either









[II.2.9.3.1.


without any conditions, and















(2)
and/or









[II.2.9.3.2.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.9.3.3.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.9.3.4.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 7, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.9.3.5.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 8, of Annex V to Delegated Regulation (EU) 2020/689, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]]



















(2)
either









[II.2.10.


The animals are intended for a Member State or zone thereof listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 of the European Parliament and of the Council as having a negligible risk status for classical scrapie or for a Member State listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme, and:







(2)
either



[come from a holding situated in a Member State or zone thereof listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie;]











(2)
and/or



[come from a holding recognised as having a negligible risk of classical scrapie in accordance with Chapter A, Section A, point 1.2, of Annex VIII to Regulation (EC) No 999/2001 and listed as such by the competent authority of the Member State in accordance with Chapter A, Section A, point 1.1, of Annex VIII to Regulation (EC) No 999/2001;]











(2)
and/or



[come from a holding not subject to the measures laid down in Chapter B, points 3 and 4, of Annex VII to Regulation (EC) No 999/2001 and the animals are of the ovine species and are of the ARR/ARR prion protein genotype, or the animals are of the caprine species and carry at least one of the K222, D146 or S146 alleles;]











(2)
and/or



[come from and are destined for a confined establishment as defined in Article 4, point (48), of Regulation (EU) 2016/429 of the European Parliament and of the Council;]











(2)
or



[comply with the conditions set out in Chapter A, Section A, point 4.1(d), of Annex VIII to Regulation (EC) No 999/2001.]]



















(2)
or









[II.2.10.


The animals are for breeding and are intended for a Member State or zone thereof other than those listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie or other than those listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme, and:







(2)
either



[come from a holding situated in a Member State or zone of a Member State listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie;]











(2)
and/or



[come from a holding recognised as having a negligible risk of classical scrapie in accordance with Chapter A, Section A, point 1.2, of Annex VIII to Regulation (EC) No 999/2001 and listed as such by the competent authority of the Member State in accordance with Chapter A, Section A, point 1.1, of Annex VIII to Regulation (EC) No 999/2001;]











(2)
and/or



[come from a holding recognised as having a controlled risk of classical scrapie in accordance with Chapter A, Section A, point 1.3, of Annex VIII to Regulation (EC) No 999/2001 and listed as such by the competent authority of the Member State in accordance with Chapter A, Section A, point 1.1, of Annex VIII to Regulation (EC) No 999/2001;]











(2)
and/or



[come from a holding not subject to the measures laid down in Chapter B, points 3 and 4, of Annex VII to Regulation (EC) No 999/2001 and the animals are of the ovine species and are of the ARR/ARR prion protein genotype, or the animals are of the caprine species and carry at least one of the K222, D146 or S146 alleles;]











(2)
and/or



[come from and are destined for a confined establishment as defined in Article 4, point (48), of Regulation (EU) 2016/429;]











(2)
or



[comply with the conditions set out in Chapter A, Section A, point 4.1(d), of Annex VIII to Regulation (EC) No 999/2001.]]



















(2)
or









[II.2.10.


The animals are not for breeding and are intended for a Member State or zone thereof other than those listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie or other than those listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme.]














II.3.


To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause.










II.4.


Arrangements are made to transport the consignment in accordance with Article 4 of Delegated Regulation (EU) 2020/688.










II.5.


This animal health certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of animals, the period of validity of the certificate may be extended by the duration of the journey by waterway/sea.











(2) (6) [II.6.


Since the date of departure from their establishments of origin and prior to the date of arrival to this establishment approved for assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and











(2)
either



[they come from their establishments of origin.]]











(2)
or



[at least one of the animals of the consignment has undergone one assembly operation in an approved establishment.]]











(2)
or



[at least one of the animals of the consignment has undergone two assembly operations in the approved establishments.]]





Animal welfare attestation

At the time of inspection, the animals covered by this animal health certificate were fit to be transported in accordance with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start on … (insert date)
(7) (8).

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:








Box reference I.11


:


“Place of dispatch”: Indicate an establishment of the origin of the animals in the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.




Box reference I.12


:


“Place of destination”: Indicate an establishment of the final destination of the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.




Box reference I.17


:



                                          “Accompanying documents”: In case the animals are dispatched from an establishment approved for assembly operations in the Member State of origin, the reference number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, may be indicated.
In case the animals are dispatched from an establishment approved for assembly operations in the Member State of passage, the reference number(s) of the certificate(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, shall be indicated.




Box reference I.30


:


“Identification number”: Indicate identification codes of the animals in the consignment identified in accordance with Article 45(2) or (4) or Article 46(1) of Delegated Regulation (EU) 2019/2035.





Part II:








(1)



There may be one or more animals in the consignment.











(2)



Delete if not applicable.











(3)



Insert the name of the disease(s).











(4)



Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements.











(5)



Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 126(1), points (b)(ii) and (iii), of Regulation (EU) 2016/429.











(6)



Applicable in case the consignment is dispatched from the establishment approved for assembly operations.











(7)



In the case where a consignment is grouped in an establishment approved for assembly operations and comprises animals that were loaded on different dates, the date which the journey commenced for the whole consignment is considered to be the earliest date when any part of the consignment left the establishment of origin.











(8)



This statement does not exempt transporters from their obligation in accordance with Union rules in force in particular regarding the fitness to be transported.

















Official veterinarian





Name (in capital letters)


 


Qualification and title


 




Local Control Unit name


 


Local Control Unit code


 




Date


 


 


 




Stamp


 


Signature’


 




;










(3)


Chapter 9 is replaced by the following:

                                 ‘CHAPTER 9

MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF CAMELID ANIMALS NOT INTENDED FOR SLAUGHTER (MODEL “CAM-INTRA-X”)


Part I:   Description of consignment








EUROPEAN UNION




INTRA




















I.1




Consignor



 



I.2




IMSOC reference



 


 




 


Name


 



I.2a




Local reference



 


 




 


Address


 



I.3




Central Competent Authority



 



QR CODE





 


 




 


Country


ISO country code



I.4




Local Competent Authority



 


 





I.5




Consignee



 



I.6




Operator conducting assembly operations independently of an establishment





 


Name


 


 


Name


Registration No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.7




Country of origin



ISO country code



I.9




Country of destination



ISO country code





I.8




Region of origin



Code



I.10




Region of destination



Code





I.11




Place of dispatch



 



I.12




Place of destination



 




 


Name


Registration/Approval No


 


Name


Registration/Approval No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.13




Place of loading




I.14




Date and time of departure



















I.15




Means of transport



 



I.16




Transporter





 


☐ Vessel


☐ Aircraft


 


Name


Registration/Authorisation No




 


Address


 




 


☐ Railway


☐ Road vehicle


 


Country


ISO country code





I.17




Accompanying documents





 


Identification


☐ Other


 


Type


Code




 


Document


 


Country


ISO country code




 


Commercial document reference


 

















I.18




Transport conditions



☐ Ambient


☐ Chilled


☐ Frozen





I.19




Container number/Seal number





 


Container No


Seal No


 

















I.20




Certified as or for





☐ Further keeping


☐ Slaughter


☐ Confined establishment


☐ Germinal products




☐ Registered equine animal


☐ Travelling circus/animal act


☐ Exhibition


☐ Event or activity near borders




☐ Release into the wild


☐ Dispatch centre


☐ Relaying area/purification centre


☐ Ornamental aquaculture establishment




☐ Further processing


☐ Organic fertilizers and soil improvers


☐ Technical use


☐ Quarantine or similar establishment




☐ Products for human consumption


☐ Pollination


☐ Live aquatic animals for human consumption


☐ Other















I.21




☐ For transit through a third country





 


Third country


ISO country code




 


Exit point


BCP code




 


Entry point


BCP code


















I.22




☐ For transit through Member State(s)




I.23




☐ For export





 


Member State


ISO country code


 


Third country


ISO country code




 


Member State


ISO country code


 


Exit point


BCP code




 


Member State


ISO country code


 


 


 


















I.24




Estimated journey time




I.25




Journey log



☐ yes


☐ no





I.26




Total number of packages




I.27




Total quantity






I.28




Total net weight/gross weight (kg)




I.29




Total space foreseen for the consignment






















I.30




Description of consignment





CN code


Species


Subspecies/Category


Sex


Identification system


Identification number


Age


Quantity




 


 


 


 


 


 


 


Type




Region of origin


 


Cold store


 


Identification mark


Type of packaging


 


Net weight




 


 


 


 


 


 


 


 




Slaughterhouse


 


Treatment type


 


Nature of commodity


Number of packages


 


Batch No




 


 


 


 


 


 


 


 




 


 


Date of collection/production


 


Manufacturing plant


Approval or registration number of plant/establishment/centre


Test


 





Part II:   Certification












EUROPEAN UNION




Certificate model CAM-INTRA-X





 



II. Health information




II.a




Certificate reference




II.b




IMSOC reference










I, the undersigned official veterinarian, hereby certify that:






II.1.


The camelid animals (1) of the consignment described in Part I meet the following requirements:






II.1.1.


They are identified as provided for in Article 73 of Commission Delegated Regulation (EU) 2019/2035.










II.1.2.


They, for at least 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age:






II.1.2.1.


have been continuously resident in the establishment of origin;










II.1.2.2.


have not been in contact with kept camelid animals of a lower health status or subject to movement restrictions for animal health reasons;










II.1.2.3.


have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the last 30 days prior to the date of departure of the consignment.














II.1.3.


They have not shown clinical signs or symptoms of diseases listed for camelid animals during the clinical examination which was carried out, within the last 24 hours prior to the time of departure of the consignment, on … (insert date dd/mm/yyyy).














II.2.


According to official information, the animals described in Part I meet the following health requirements:






II.2.1.









(2)
either



[They come from establishments or zones not subject to movement restrictions affecting camelid animals and established for reasons of diseases listed for those species or diseases subject to emergency measures relevant for those species, and they have not been in contact with kept animals of a listed species of a lower health status for an adequate period.]











(2)
or



[They come from establishments or zones subject to movement restrictions affecting camelid animals and established for … (3), but derogations from movement restrictions have been granted, and:











(2)



[they comply with the requirements set out in … (4);]]











(2)



[and in particular, they are … (5).]]














II.2.2.


They come from establishments in which infection with Brucella abortus, B. melitensis and B. suis in camelid animals has not been reported during the last 42 days prior to the date of departure of the consignment, and the animals of the consignment have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on a sample taken during the last 30 days prior to the date of departure of the consignment, and in the case of post-parturient females taken at least 30 days after parturition.










II.2.3.


They come from establishments in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the camelid animals kept in the establishments during at least 12 months prior to the date of departure of the consignment, as referred to in Article 23(1), point (e), of Delegated Regulation (EU) 2020/688.










II.2.4.


They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of departure of the consignment.










II.2.5.


They come from establishments situated within an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus:











(2)
either



[has not been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure and the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX to Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally disease-free area;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the seasonally disease-free area;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure and the animals have been protected against attacks by vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX to Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been vaccinated against infection with epizootic haemorrhagic disease virus and the animals are within the immunity period guaranteed in the specifications of the vaccine and:







(2)
either



[they have been vaccinated at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[they have been vaccinated with an inactivated vaccine and have been subject to a PCR test, with negative results on samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals comply with specific risk-mitigating measures defined by the competent authority of the Member State of destination and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and



[the requirements laid down in Article 23(1), third subparagraph, of Delegated Regulation (EU) 2020/688 are fulfilled.]










II.2.6.


They come from establishments in which anthrax in ungulates has not been reported during the last 15 days prior to the date of departure of the consignment.










II.2.7.


They come from establishments in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of departure of the consignment, and











(2)
either



[surra has not been reported in the establishments during the last 2 years prior to the date of departure of the consignment.]











(2)
or



[surra has been reported during the last 2 years prior to the date of departure of the consignment, and following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments.]















(2)
either









[II.2.8.


They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of departure of the consignment and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) within the last 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]















(2)
and/or









[II.2.8.


They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and:











(2)
either









[II.2.8.1.


have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689:











(2)
either









[II.2.8.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]















(2)
and/or









[II.2.8.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]]



















(2)
and/or









[II.2.8.2.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:











(2)
either









[II.2.8.2.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.2.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.8.2.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.8.3.


have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the departure of the consignment in that Member State or zone thereof and are within the immunity period guaranteed in the specifications of the vaccine, and:











(2)
either









[II.2.8.3.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.3.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]



















(2)
and/or









[II.2.8.4.


have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported during the last 2 years prior to the date of departure of the consignment in that Member State or zone thereof, and:











(2)
either









[II.2.8.4.1.


the serological test has been carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.4.2.


the serological test has been carried out on samples collected at least 30 days prior to the date of the departure of the consignment and the animal has been subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]]























(2)
and/or









[II.2.8.


They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and:











(2)
either









[II.2.8.1.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:











(2)
either









[II.2.8.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.8.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.8.2.


have been kept for the last 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or within an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and:











(2)
either









[II.2.8.2.1.


the animals have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of the departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept, and are within the period of immunity guaranteed in the specifications of the vaccine, and:











(2)
either









[II.2.8.2.1.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.8.2.1.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]]



















(2)
and/or









[II.2.8.2.2.


the animals have been immunised against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept, and:











(2)
either









[II.2.8.2.2.1.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.8.2.2.2.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days prior to the date of departure of the consignment and to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]]]



























(2)
and/or









[II.2.8.


They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof:











(2)
either









[II.2.8.1.


with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:











(2)
either









[II.2.8.1.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.1.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.1.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.1.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled]]]















(2)
and/or









[II.2.8.2.


with an approved eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689 and:











(2)
either









[II.2.8.2.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]]















(2)
and/or









[II.2.8.2.


neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised:











(2)
either









[II.2.8.2.1.


without any conditions, and















(2)
and/or









[II.2.8.2.2.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.2.3.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.2.4.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 7, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.2.5.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 8, of Annex V to Delegated Regulation (EU) 2020/689, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]]



















(2)









[II.2.9.


They are moved to a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis or with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine animals and they come from an establishment in which infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in camelid animals has not been reported during the last 30 days prior to the date of departure of the consignment.]














II.3.


To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause.










II.4.


Arrangements are made to transport the consignment in accordance with Article 4 of Delegated Regulation (EU) 2020/688.










II.5.


This animal health certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of animals, the period of validity of the certificate may be extended by the duration of the journey by waterway/sea.











(2) (6) [II.6.


Since the date of departure from their establishments of origin and prior to the date of arrival to this establishment approved for assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and











(2)
either



[they come from their establishments of origin.]]











(2)
or



[at least one of the animals of the consignment has undergone one assembly operation in an approved establishment.]]











(2)
or



[at least one of the animals of the consignment has undergone two assembly operations in the approved establishments.]]





Animal welfare attestation

At the time of inspection, the animals covered by this animal health certificate were fit to be transported in accordance with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start on … (insert date).

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:








Box reference I.11


:


“Place of dispatch”: Indicate an establishment of the origin of the animals in the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429 of the European Parliament and of the Council.




Box reference I.12


:


“Place of destination”: Indicate an establishment of the final destination of the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.




Box reference I.17


:



                                          “Accompanying documents”: In case the animals are dispatched from an establishment approved for assembly operations in the Member State of origin, the reference number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, may be indicated.
In case the animals are dispatched from an establishment approved for assembly operations in the Member State of passage, the reference number(s) of the certificate(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, shall be indicated.




Box reference I.30


:


“Identification number”: Indicate identification codes of the animals in the consignment identified in accordance with Article 73 of Delegated Regulation (EU) 2019/2035.





Part II:








(1)



There may be one or more animals in the consignment.











(2)



Delete if not applicable.











(3)



Insert the name of the disease(s).











(4)



Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements.











(5)



Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 126(1), points (b)(ii) and (iii), of Regulation (EU) 2016/429.











(6)



Applicable in case the consignment is dispatched from the establishment approved for assembly operations.

















Official veterinarian





Name (in capital letters)


 


Qualification and title


 




Local Control Unit name


 


Local Control Unit code


 




Date


 


 


 




Stamp


 


Signature’


 




;










(4)


Chapter 11 is replaced by the following:

                                 ‘CHAPTER 11

MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF CERVID ANIMALS NOT INTENDED FOR SLAUGHTER (MODEL “CER-INTRA-X”)


Part I:   Description of consignment








EUROPEAN UNION




INTRA




















I.1




Consignor



 



I.2




IMSOC reference



 


 




 


Name


 



I.2a




Local reference



 


 




 


Address


 



I.3




Central Competent Authority



 



QR CODE





 


 




 


Country


ISO country code



I.4




Local Competent Authority



 


 





I.5




Consignee



 



I.6




Operator conducting assembly operations independently of an establishment





 


Name


 


 


Name


Registration No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.7




Country of origin



ISO country code



I.9




Country of destination



ISO country code





I.8




Region of origin



Code



I.10




Region of destination



Code





I.11




Place of dispatch



 



I.12




Place of destination



 




 


Name


Registration/Approval No


 


Name


Registration/Approval No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.13




Place of loading




I.14




Date and time of departure



















I.15




Means of transport



 



I.16




Transporter





 


☐ Vessel


☐ Aircraft


 


Name


Registration/Authorisation No




 


Address


 




 


☐ Railway


☐ Road vehicle


 


Country


ISO country code





I.17




Accompanying documents





 


Identification


☐ Other


 


Type


Code




 


Document


 


Country


ISO country code




 


Commercial document reference


 

















I.18




Transport conditions



☐ Ambient


☐ Chilled


☐ Frozen





I.19




Container number/Seal number





 


Container No


Seal No


 

















I.20




Certified as or for





☐ Further keeping


☐ Slaughter


☐ Confined establishment


☐ Germinal products




☐ Registered equine animal


☐ Travelling circus/animal act


☐ Exhibition


☐ Event or activity near borders




☐ Release into the wild


☐ Dispatch centre


☐ Relaying area/purification centre


☐ Ornamental aquaculture establishment




☐ Further processing


☐ Organic fertilizers and soil improvers


☐ Technical use


☐ Quarantine or similar establishment




☐ Products for human consumption


☐ Pollination


☐ Live aquatic animals for human consumption


☐ Other















I.21




☐ For transit through a third country





 


Third country


ISO country code




 


Exit point


BCP code




 


Entry point


BCP code


















I.22




☐ For transit through Member State(s)




I.23




☐ For export





 


Member State


ISO country code


 


Third country


ISO country code




 


Member State


ISO country code


 


Exit point


BCP code




 


Member State


ISO country code


 


 


 


















I.24




Estimated journey time




I.25




Journey log



☐ yes


☐ no





I.26




Total number of packages




I.27




Total quantity






I.28




Total net weight/gross weight (kg)




I.29




Total space foreseen for the consignment






















I.30




Description of consignment





CN code


Species


Subspecies/Category


Sex


Identification system


Identification number


Age


Quantity




 


 


 


 


 


 


 


Type




Region of origin


 


Cold store


 


Identification mark


Type of packaging


 


Net weight




 


 


 


 


 


 


 


 




Slaughterhouse


 


Treatment type


 


Nature of commodity


Number of packages


 


Batch No




 


 


 


 


 


 


 


 




 


 


Date of collection/production


 


Manufacturing plant


Approval or registration number of plant/establishment/centre


Test


 





Part II:   Certification












EUROPEAN UNION




Certificate model CER-INTRA-X





 



II. Health information




II.a




Certificate reference




II.b




IMSOC reference










I, the undersigned official veterinarian, hereby certify that:






II.1.


The cervid animals (1) of the consignment described in Part I meet the following requirements:






II.1.1.


They are identified as provided for in Article 73 or Article 74 of Commission Delegated Regulation (EU) 2019/2035.










II.1.2.


They, for at least 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age:






II.1.2.1.


have been continuously resident in the establishment of origin;










II.1.2.2.


have not been in contact with kept cervid animals of a lower health status or subject to movement restrictions for animal health reasons;










II.1.2.3.


have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the last 30 days prior to the date of departure of the consignment.














II.1.3.


They have not shown clinical signs or symptoms of diseases listed for cervid animals during the clinical examination which was carried out, within the last 24 hours prior to the time of departure of the consignment, on … (insert date dd/mm/yyyy).














II.2.


According to official information, the animals described in Part I meet the following health requirements:






II.2.1.









(2)
either



[They come from establishments or zones not subject to movement restrictions affecting cervid animals and established for reasons of diseases listed for those species or diseases subject to emergency measures relevant for those species, and they have not been in contact with kept animals of a listed species of a lower health status for an adequate period.]











(2)
or



[They come from establishments or zones subject to movement restrictions affecting cervid animals and established for … (3), but derogations from movement restrictions have been granted, and:











(2)



[they comply with the requirements set out in … (4);]]











(2)



[and in particular, they are … (5).]]














II.2.2.


They come from establishments in which infection with Brucella abortus, B. melitensis and B. suis in cervid animals has not been reported during the last 42 days prior to the date of departure of the consignment.










II.2.3.


They come from establishments in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the cervid animals kept in the establishments during at least 12 months prior to the date of departure of the consignment, as referred to in Article 26(1), point (e), of Commission Delegated Regulation (EU) 2020/688.










II.2.4.


They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of departure of the consignment.










II.2.5.


They come from establishments situated within an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus:











(2)
either



[has not been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure and the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX to Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally disease-free area;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the seasonally disease-free area;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been protected against attacks by vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX to Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been vaccinated against infection with epizootic haemorrhagic disease virus and the animals are within the immunity period guaranteed in the specifications of the vaccine and:







(2)
either



[they have been vaccinated at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[they have been vaccinated with an inactivated vaccine and have been subject to a PCR test, with negative results on samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals comply with specific risk-mitigating measures defined by the competent authority of the Member State of destination and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and



[the requirements laid down in Article 26(1), third subparagraph, of Delegated Regulation (EU) 2020/688 are fulfilled.]










II.2.6.


They come from establishments in which anthrax in ungulates has not been reported during the last 15 days prior to the date of departure of the consignment.










II.2.7.


They come from establishments in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of departure of the consignment, and











(2)
either



[surra has not been reported in the establishments during the last 2 years prior to the date of departure of the consignment.]











(2)
or



[surra has been reported during the last 2 years prior to the date of departure of the consignment, and following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments.]















(2)
either









[II.2.8.


They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of departure of the consignment and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) in the last 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]















(2)
and/or









[II.2.8.


They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and:











(2)
either









[II.2.8.1.


have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689:











(2)
either









[II.2.8.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]















(2)
and/or









[II.2.8.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]]



















(2)
and/or









[II.2.8.2.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:











(2)
either









[II.2.8.2.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.2.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.8.2.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.8.3.


have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment in that Member State or zone thereof and are within the immunity period guaranteed in the specifications of the vaccine and:











(2)
either









[II.2.8.3.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.3.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]



















(2)
and/or









[II.2.8.4.


have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported during the last 2 years prior to the date of departure of the consignment in that Member State or zone thereof, and:











(2)
either









[II.2.8.4.1.


the serological test has been carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.4.2.


the serological test has been carried out on samples collected at least 30 days prior to the date of the departure of the consignment and the animals have been subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]]























(2)
and/or









[II.2.8.


They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and:











(2)
either









[II.2.8.1.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:











(2)
either









[II.2.8.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.8.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.8.2.


have been kept for the last 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or within an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and:











(2)
either









[II.2.8.2.1.


the animals have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept and are within the immunity period guaranteed in the specifications of the vaccine and:











(2)
either









[II.2.8.2.1.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.8.2.1.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]]



















(2)
and/or









[II.2.8.2.2.


the animals have been immunised against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept, and:











(2)
either









[II.2.8.2.2.1.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days prior to the date of departure of the consignment.]]]















(2)
and/or









[II.2.8.2.2.2.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days prior to the date of departure of the consignment and to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment.]]]]



























(2)
and/or









[II.2.8.


They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof:











(2)
either









[II.2.8.1.


with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:











(2)
either









[II.2.8.1.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.1.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.1.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.1.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]]















(2)
and/or









[II.2.8.2.


with an approved eradication program for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689 and:











(2)
either









[II.2.8.2.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]]















(2)
and/or









[II.2.8.3.


neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised:











(2)
either









[II.2.8.3.1.


without any conditions, and:















(2)
and/or









[II.2.8.3.2.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.3.3.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.3.4.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 7, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.3.5.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 8, of Annex V to Delegated Regulation (EU) 2020/689, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]]


















II.2.9.


With regard to chronic wasting disease (CWD), they







(2)
either









[II.2.9.1.


are moved from a Member State other than a Member State listed in Chapter A, Section C, point 1.1, of Annex VIII to Regulation (EC) 999/2001 of the European Parliament and of the Council.]















(2)
or









[II.2.9.2.


are semi-domesticated reindeer moved from Norway to an area in Finland listed in Chapter A, Section C, point 1.2(a), of Annex VIII to Regulation (EC) 999/2001 for seasonal grazing in Finland.]















(2)
or









[II.2.9.3.


are semi-domesticated reindeer moved from Norway to an area in Sweden listed in Chapter A, Section C, point 1.2(b), of Annex VIII to Regulation (EC) 999/2001 after seasonal grazing in Norway, or after having taken part in sporting or cultural events in Norway, or for seasonal grazing in Sweden, or for sporting or cultural events in Sweden, and the competent authority of Sweden has given its prior written consent to such movement.]















(2)
or









[II.2.9.4.


are semi-domesticated reindeer which have grazed in Norway in the area located between the Norwegian-Finnish border, and the Norwegian-Finnish Reindeer Fence and are returning to Finland.]















(2)
or









[II.2.9.5.


are moved from an area in Norway to another area in Norway with a transit through Sweden or Finland, and the competent authority of Sweden or Finland has given its prior written consent to such transit.]















(2)
or









[II.2.9.6.


are moved from an area in Sweden listed in Chapter A, Section C, point 1.2(b), of Annex VIII to Regulation (EC) 999/2001 to Norway, and the competent authority of Norway has given its prior written consent to such movement.]















(2)
or









[II.2.9.7.


are forest reindeer moved from an area in Sweden listed in Chapter A, Section C, point 1.2(b), of Annex VIII to Regulation (EC) 999/2001 to Finland, and the competent authority of Finland has given its prior written consent to such movement.]















(2)
or









[II.2.9.8.


are moved from an area in a Member State listed in Chapter A, Section C, point 1.1, of Annex VIII to Regulation (EC) 999/2001, other than an area listed in Chapter A, Section C, point 1.2, of Annex VIII to that Regulation, to another Member State listed in Chapter A, Section C, point 1.1, of Annex VIII to that Regulation, or to Norway, and the competent authority of destination has given its prior written consent to such movement.]















(2)
or









[II.2.9.9.


are moved from a confined establishment, as defined in Article 4, point (48), of Regulation (EU) 2016/429 of the European Parliament and of the Council, in a Member State listed in Chapter A, Section C, point 1.1, of Annex VIII to Regulation (EC) 999/2001, to a confined establishment in another Member State, and the competent authority of the Member State of destination has given its prior written consent to such movement.]



















(2)









[II.2.10.


They are moved to a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis or with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine animals and they come from an establishment in which infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in cervid animals has not been reported during the last 30 days prior to the date of departure of the consignment.]














II.3.


To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause.










II.4.


Arrangements are made to transport the consignment in accordance with Article 4 of Delegated Regulation (EU) 2020/688.










II.5.


This animal health certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of animals, the period of validity of the certificate may be extended by the duration of the journey by waterway/sea.











(2) (6) [II.6.


Since the date of departure from their establishments of origin and prior to the date of arrival to this establishment approved for assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and











(2)
either



[they come from their establishments of origin.]]











(2)
or



[at least one of the animals of the consignment has undergone one assembly operation in an approved establishment.]]











(2)
or



[at least one of the animals of the consignment has undergone two assembly operations in the approved establishments.]]





Animal welfare attestation

At the time of inspection, the animals covered by this animal health certificate were fit to be transported in accordance with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start on … (insert date).

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:








Box reference I.11


:


“Place of dispatch”: Indicate an establishment of the origin of the animals in the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.




Box reference I.12


:


“Place of destination”: Indicate an establishment of the final destination of the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.




Box reference I.17


:



                                          “Accompanying documents”: In case the animals are dispatched from an establishment approved for assembly operations in the Member State of origin, the reference number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, may be indicated.
In case the animals are dispatched from an establishment approved for assembly operations in the Member State of passage, the reference number(s) of the certificate(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, shall be indicated.




Box reference I.30


:


“Identification number”: Indicate identification codes of the animals in the consignment identified in accordance with Article 73 or 74 of Delegated Regulation (EU) 2019/2035.





Part II:








(1)



There may be one or more animals in the consignment.











(2)



Delete if not applicable.











(3)



Insert the name of the disease(s).











(4)



Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements.











(5)



Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 126(1), points (b)(ii) and (iii), of Regulation (EU) 2016/429.











(6)



Applicable in case the consignment is dispatched from the establishment approved for assembly operations.

















Official veterinarian





Name (in capital letters)


 


Qualification and title


 




Local Control Unit name


 


Local Control Unit code


 




Date


 


 


 




Stamp


 


Signature’


 




;










(5)


Chapter 13 is replaced by the following:

                                 ‘CHAPTER 13

MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF KEPT UNGULATES OTHER THAN BOVINE, OVINE, CAPRINE, PORCINE, EQUINE, CAMELID AND CERVID ANIMALS NOT INTENDED FOR SLAUGHTER (MODEL “OTHER-UNGULATES-INTRA-X”)


Part I:   Description of consignment








EUROPEAN UNION




INTRA




















I.1




Consignor



 



I.2




IMSOC reference



 


 




 


Name


 



I.2a




Local reference



 


 




 


Address


 



I.3




Central Competent Authority



 



QR CODE





 


 




 


Country


ISO country code



I.4




Local Competent Authority



 


 





I.5




Consignee



 



I.6




Operator conducting assembly operations independently of an establishment





 


Name


 


 


Name


Registration No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.7




Country of origin



ISO country code



I.9




Country of destination



ISO country code





I.8




Region of origin



Code



I.10




Region of destination



Code





I.11




Place of dispatch



 



I.12




Place of destination



 




 


Name


Registration/Approval No


 


Name


Registration/Approval No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.13




Place of loading




I.14




Date and time of departure



















I.15




Means of transport



 



I.16




Transporter





 


☐ Vessel


☐ Aircraft


 


Name


Registration/Authorisation No




 


Address


 




 


☐ Railway


☐ Road vehicle


 


Country


ISO country code





I.17




Accompanying documents





 


Identification


☐ Other


 


Type


Code




 


Document


 


Country


ISO country code




 


Commercial document reference


 

















I.18




Transport conditions



☐ Ambient


☐ Chilled


☐ Frozen





I.19




Container number/Seal number





 


Container No


Seal No


 

















I.20




Certified as or for





☐ Further keeping


☐ Slaughter


☐ Confined establishment


☐ Germinal products




☐ Registered equine animal


☐ Travelling circus/animal act


☐ Exhibition


☐ Event or activity near borders




☐ Release into the wild


☐ Dispatch centre


☐ Relaying area/purification centre


☐ Ornamental aquaculture establishment




☐ Further processing


☐ Organic fertilizers and soil improvers


☐ Technical use


☐ Quarantine or similar establishment




☐ Products for human consumption


☐ Pollination


☐ Live aquatic animals for human consumption


☐ Other















I.21




☐ For transit through a third country





 


Third country


ISO country code




 


Exit point


BCP code




 


Entry point


BCP code


















I.22




☐ For transit through Member State(s)




I.23




☐ For export





 


Member State


ISO country code


 


Third country


ISO country code




 


Member State


ISO country code


 


Exit point


BCP code




 


Member State


ISO country code


 


 


 


















I.24




Estimated journey time




I.25




Journey log



☐ yes


☐ no





I.26




Total number of packages




I.27




Total quantity






I.28




Total net weight/gross weight (kg)




I.29




Total space foreseen for the consignment






















I.30




Description of consignment





CN code


Species


Subspecies/Category


Sex


Identification system


Identification number


Age


Quantity




 


 


 


 


 


 


 


Type




Region of origin


 


Cold store


 


Identification mark


Type of packaging


 


Net weight




 


 


 


 


 


 


 


 




Slaughterhouse


 


Treatment type


 


Nature of commodity


Number of packages


 


Batch No




 


 


 


 


 


 


 


 




 


 


Date of collection/production


 


Manufacturing plant


Approval or registration number of plant/establishment/centre


Test


 





Part II:   Certification












EUROPEAN UNION




Certificate model OTHER-UNGULATES-INTRA-X





 



II. Health information




II.a




Certificate reference




II.b




IMSOC reference










I, the undersigned official veterinarian, hereby certify that:






II.1.


The animals (1) of the consignment described in Part I are kept ungulates other than bovine, ovine, caprine, porcine, equine, camelid and cervid animals and meet the following requirements:






II.1.1.


They are identified as provided for in Article 117 of Regulation (EU) 2016/429 of the European Parliament and of the Council.










II.1.2.


They, for at least 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age:






II.1.2.1.


have been continuously resident in the establishment of origin;










II.1.2.2.


have not been in contact with other kept ungulates of a lower health status or subject to movement restrictions for animal health reasons;










II.1.2.3.


have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the last 30 days prior to the date of departure of the consignment.














II.1.3.


They have not shown clinical signs or symptoms of diseases listed for ungulates of the species concerned during the clinical examination which was carried out, within 24 hours prior to the time of departure of the consignment, on … (insert date dd/mm/yyyy).














II.2.


According to official information, the animals described in Part I meet the following health requirements:






II.2.1.









(2)
either



[They come from establishments or zones not subject to movement restrictions affecting the species of animals to be moved and established for reasons of diseases listed for those species or diseases subject to emergency measures relevant for those species, and they have not been in contact with kept animals of a listed species of a lower health status for an adequate period.]











(2)
or



[They come from establishments or zones subject to movement restrictions affecting the species of animals to be moved and established for … (3), but derogations from movement restrictions have been granted, and:











(2)



[they comply with the requirements set out in … (4);]]











(2)



[and in particular. they are … (5).]]














II.2.2.


They come from establishments in which anthrax in ungulates has not been reported during the last 15 days prior to the date of departure of the consignment.















(2)









[II.2.3.


They come from establishments in which infection with Brucella abortus, B. melitensis and B. suis in kept animals of listed species has not been reported during the last 42 days prior to the date of departure of the consignment.]















(2)









[II.2.4.


They come from establishments in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in kept animals of listed species has not been reported during the last 42 days prior to the date of departure of the consignment.]















(2)









[II.2.5.


They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of departure of the consignment.]















(2)









[II.2.6.


They come from establishments situated within an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus:











(2)
either



[has not been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX to Commission Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally disease-free area;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the seasonally disease-free area;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been protected against attacks by vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX to Delegated Regulation (EU) 2020/688:







(2)
either



[for at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]











(2)
and/or



[for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been vaccinated against infection with epizootic haemorrhagic disease virus and the animals are within the immunity period guaranteed in the specifications of the vaccine and:







(2)
either



[they have been vaccinated at least 60 days prior to the date of departure of the consignment;]]











(2)
and/or



[they have been vaccinated with an inactivated vaccine and have been subject to a PCR test, with negative results on samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]]















(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and/or



[has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals comply with specific risk-mitigating measures defined by the competent authority of the Member State of destination and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;]











(2)
and



[the requirements laid down in Article 29(1), third subparagraph, of Delegated Regulation (EU) 2020/688 are fulfilled.]















(2)









[II.2.7.


They come from establishments in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of departure of the consignment, and











(2)
either



[surra has not been reported in the establishments during the last 2 years prior to the date of departure of the consignment.]]











(2)
or



[surra has been reported during the last 2 years prior to departure of the consignment, and following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments.]]















(2)
either









[II.2.8.


They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of departure of the consignment and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) during the last 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]















(2)
and/or









[II.2.8.


They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and:











(2)
either









[II.2.8.1.


have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689:











(2)
either









[II.2.8.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]















(2)
and/or









[II.2.8.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]]



















(2)
and/or









[II.2.8.2.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:











(2)
either









[II.2.8.2.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.2.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.8.2.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.8.3.


have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported in that Member State or zone thereof during the last 2 years prior to the date of departure of the consignment and are within the immunity period guaranteed in the specifications of the vaccine, and:











(2)
either









[II.2.8.3.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.3.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]



















(2)
and/or









[II.2.8.4.


have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported in that Member State or zone thereof during the last 2 years prior to the date of departure of the consignment, and:











(2)
either









[II.2.8.4.1.


the serological test has been carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.4.2.


the serological test has been carried out on samples collected at least 30 days prior to the date of the departure of the consignment and the animals have been subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]]























(2)
and/or









[II.2.8.


They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:











(2)
either









[II.2.8.1.


have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:











(2)
either









[II.2.8.1.1.


for at least 60 days prior to the date of departure of the consignment;]]















(2)
and/or









[II.2.8.1.2.


for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]















(2)
and/or









[II.2.8.1.3.


for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]



















(2)
and/or









[II.2.8.2.


have been kept for the last 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or within an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and:











(2)
either









[II.2.8.2.1.


the animals have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept and are within the immunity period guaranteed in the specifications of the vaccine, and:











(2)
either









[II.2.8.2.1.1.


have been vaccinated more than 60 days prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.8.2.1.2.


have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]]



















(2)
and/or









[II.2.8.2.2.


the animals have been immunised against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept, and:











(2)
either









[II.2.8.2.2.1.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]]















(2)
and/or









[II.2.8.2.2.2.


the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days prior to the date of the movement and to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]]]



























(2)
and/or









[II.2.8.


They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof:











(2)
either









[II.2.8.1.


with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:











(2)
either









[II.2.8.1.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Regulation, and















(2)
and/or









[II.2.8.1.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Regulation, and















(2)
and/or









[II.2.8.1.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Regulation, and















(2)
and/or









[II.2.8.1.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]]















(2)
and/or









[II.2.8.2.


with an approved eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and:











(2)
either









[II.2.8.2.1.


Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.2.


Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.3.


Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and















(2)
and/or









[II.2.8.2.4.


Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]]















(2)
and/or









[II.2.8.3.


neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised:











(2)
either









[II.2.8.3.1.


without any conditions, and















(2)
and/or









[II.2.8.3.2.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.3.3.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.3.4.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 7, of Annex V to Delegated Regulation (EU) 2020/689, and















(2)
and/or









[II.2.8.3.5.


subject to the conditions referred to in Part II, Chapter 2, Section 1, point 8, of Annex V to Delegated Regulation (EU) 2020/689, and




the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]]]


















II.3.


To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause.










II.4.


Arrangements are made to transport the consignment in accordance with Article 4 of Delegated Regulation (EU) 2020/688.










II.5.


This animal health certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of animals, the period of validity of the certificate may be extended by the duration of the journey by waterway/sea.











(2)(6) [II.6.


Since the date of departure from their establishments of origin and prior to the date of arrival to this establishment approved for assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and











(2)
either



[they come from their establishments of origin.]]











(2)
or



[at least one of the animals of the consignment has undergone one assembly operation in an approved establishment.]]











(2)
or



[at least one of the animals of the consignment has undergone two assembly operations in the approved establishments.]]





Animal welfare attestation

At the time of inspection, the animals covered by this animal health certificate were fit to be transported in accordance with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start on … (insert date).

Notes

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:








Box reference I.11


:


“Place of dispatch”: Indicate an establishment of the origin of the animals in the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.




Box reference I.12


:


“Place of destination”: Indicate an establishment of the final destination of the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.




Box reference I.17


:



                                          “Accompanying documents”: In case the animals are dispatched from an establishment approved for assembly operations in the Member State of origin, the reference number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, may be indicated.
In case the animals are dispatched from an establishment approved for assembly operations in the Member State of passage, the reference number(s) of the certificate(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, shall be indicated.




Box reference I.30


:


“Identification number”: Indicate identification number of each animal.





Part II:








(1)



There may be one or more animals in the consignment.











(2)



Delete if not applicable.











(3)



Insert the name of the disease(s).











(4)



Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements.











(5)



Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 126(1), points (b)(ii) and (iii), of Regulation (EU) 2016/429.











(6)



Applicable in case the consignment is dispatched from the establishment approved for assembly operations.

















Official veterinarian





Name (in capital letters)


 


Qualification and title


 




Local Control Unit name


 


Local Control Unit code


 




Date


 


 


 




Stamp


 


Signature’


 




;










(6)


Chapter 30 is replaced by the following:

                                 ‘CHAPTER 30

MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF CONSIGNMENTS OF SEMEN OF OVINE AND CAPRINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/686 AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “OV/CAP-SEM-A-INTRA”)


Part I:   Description of consignment








EUROPEAN UNION




INTRA




















I.1




Consignor



 



I.2




IMSOC reference



 


 




 


Name


 



I.2a




Local reference



 


 




 


Address


 



I.3




Central Competent Authority



 



QR CODE





 


 




 


Country


ISO country code



I.4




Local Competent Authority



 


 





I.5




Consignee



 



I.6




Operator conducting assembly operations independently of an establishment





 


Name


 


 


Name


Registration No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.7




Country of origin



ISO country code



I.9




Country of destination



ISO country code





I.8




Region of origin



Code



I.10




Region of destination



Code





I.11




Place of dispatch



 



I.12




Place of destination



 




 


Name


Registration/Approval No


 


Name


Registration/Approval No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.13




Place of loading




I.14




Date and time of departure



















I.15




Means of transport



 



I.16




Transporter





 


☐ Vessel


☐ Aircraft


 


Name


Registration/Authorisation No




 


Address


 




 


☐ Railway


☐ Road vehicle


 


Country


ISO country code





I.17




Accompanying documents





 


Identification


☐ Other


 


Type


Code




 


Document


 


Country


ISO country code




 


Commercial document reference


 

















I.18




Transport conditions



☐ Ambient


☐ Chilled


☐ Frozen





I.19




Container number/Seal number





 


Container No


Seal No


 

















I.20




Certified as or for





☐ Further keeping


☐ Slaughter


☐ Confined establishment


☐ Germinal products




☐ Registered equine animal


☐ Travelling circus/animal act


☐ Exhibition


☐ Event or activity near borders




☐ Release into the wild


☐ Dispatch centre


☐ Relaying area/purification centre


☐ Ornamental aquaculture establishment




☐ Further processing


☐ Organic fertilizers and soil improvers


☐ Technical use


☐ Quarantine or similar establishment




☐ Products for human consumption


☐ Pollination


☐ Live aquatic animals for human consumption


☐ Other















I.21




☐ For transit through a third country





 


Third country


ISO country code




 


Exit point


BCP code




 


Entry point


BCP code


















I.22




☐ For transit through Member State(s)




I.23




☐ For export





 


Member State


ISO country code


 


Third country


ISO country code




 


Member State


ISO country code


 


Exit point


BCP code




 


Member State


ISO country code


 


 


 


















I.24




Estimated journey time




I.25




Journey log



☐ yes


☐ no





I.26




Total number of packages




I.27




Total quantity






I.28




Total net weight/gross weight (kg)




I.29




Total space foreseen for the consignment






















I.30




Description of consignment





CN code


Species


Subspecies/Category


Sex


Identification system


Identification number


Age


Quantity




 


 


 


 


 


 


 


Type




Region of origin


 


Cold store


 


Identification mark


Type of packaging


 


Net weight




 


 


 


 


 


 


 


 




Slaughterhouse


 


Treatment type


 


Nature of commodity


Number of packages


 


Batch No




 


 


 


 


 


 


 


 




 


 


Date of collection/production


 


Manufacturing plant


Approval or registration number of plant/establishment/centre


Test


 





Part II:   Certification












EUROPEAN UNION




Certificate model OV/CAP-SEM-A-INTRA





 



II. Health information




II.a




Certificate reference




II.b




IMSOC reference










I, the undersigned official veterinarian, hereby certify that:







(1)
either









[II.1.


The semen of [ovine] (1) [caprine] (1) animals described in Part I:










II.1.1.


has been collected, processed and stored, and dispatched from the semen collection centre (2) which is approved and kept in a register by the competent authority;










II.1.2.


has been collected, processed and stored, and dispatched from the semen collection centre which complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686;















(1)
either









[II.1.3.


is dispatched from the semen collection centre or a zone not subject to movement restrictions affecting ovine and caprine animals and established for reasons of listed diseases relevant for those species or diseases subject to emergency measures relevant for those species, or those restrictions do not apply to this semen because it was collected before the restrictions were established, and has not been in contact with other semen of a lower health status for an adequate period.]]















(1)
or









[II.1.3.


is dispatched from the semen collection centre or a zone subject to movement restrictions affecting ovine and caprine animals species and established for … (3), but derogations from movement restrictions have been granted, and:











(1)



[it complies with the requirements set out in … (4);]]]











(1)



[and in particular, it is … (5).]]]















(1)
or









[II.1.


The semen of [ovine] (1) [caprine] (1) animals described in Part I has been collected, processed and stored, and dispatched from:















(1)
either









[II.1.1.


the establishment or a zone not subject to movement restrictions affecting ovine and caprine animals and established for reasons of listed diseases relevant for those species or diseases subject to emergency measures relevant for those species, and has not been in contact with other semen of a lower health status for an adequate period;]















(1)
or









[II.1.1.


the establishment or a zone subject to movement restrictions affecting ovine and caprine animals species and established for … (3), but derogations from movement restrictions have been granted, and:











(1)



[it complies with the requirements set out in … (4);]]











(1)



[and in particular, it is … (5).]]










II.1.2.


the establishment where the donor animals are kept as referred to in Article 13 of Delegated Regulation (EU) 2020/686, and:










II.1.2.1.


the operator obtained the prior consent of the competent authority of the Member State of destination to accept the consignment;










II.1.2.2.


the donor animals have been clinically examined by a veterinarian prior to the date of semen collection;










II.1.2.3.


the operator keeps records at the establishment which include at least the information provided for in Article 8(1), point (a), of Delegated Regulation (EU) 2020/686.]














II.2.


The semen described in Part I is intended for artificial reproduction and was obtained from donor animals which:






II.2.1.


have been born and remained since birth in the Union, or have entered the Union in accordance with the requirements for entry into the Union;










II.2.2.


come, before the date of commencement of the quarantine referred to in point II.2.6, from establishments in a Member State or zone thereof, or from establishments under official control by the competent authority in a third country or territory, or a zone thereof:






II.2.2.1.


situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the establishment for at least 30 days and in which foot and mouth disease has not been reported during at least 3 months, and











(1)
either



[the donor animals were not vaccinated against foot and mouth disease;]











(1)
or



[the donor animals were vaccinated against foot and mouth disease during 12 months prior to the date of collection of the semen but not during the last 30 days immediately prior to the date of collection of the semen, and 5 % (with a minimum of five straws) of each quantity of semen taken from the donor animals at any time is submitted to a virus isolation test for foot and mouth disease with negative results;]










II.2.2.2.


free from infection with Brucella abortus, B. melitensis and B. suis and the donor animals have never been kept previously in any establishment of a lower health status;















(1) (6)









[II.2.2.3.


in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported during the last 42 days;]















(1) (7)









[II.2.2.3.


in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the caprine animals kept in the establishments during at least 12 months, as referred to in Article 15(3) of Commission Delegated Regulation (EU) 2020/688, and in case, during this period, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept in the establishment, measures were taken in accordance with Part 1, point 3, of Annex II to that Delegated Regulation;]










II.2.2.4.


in which surra (Trypanosoma evansi) has not been reported during the last 30 days, and











(1)
either



[surra has not been reported in the establishments during the last 2 years;]











(1)
or



[surra has been reported in the establishments during the last 2 years and following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments;]















(1) (6)









[II.2.2.5.


in which ovine epididymitis (Brucella ovis) has not been reported during the last 12 months;]















(1) (11)









[II.2.2.6.


where, during the last 60 days prior to their stay in the quarantine accommodation referred to in point II.2.6, they have been subjected, with negative results, to a serological test for ovine epididymitis (Brucella ovis), or any other test for ovine epididymitis (Brucella ovis) of an equivalent documented sensitivity and specificity, as required in accordance with Part 3, Chapter I, point 1(b), of Annex II to Delegated Regulation (EU) 2020/686;]














II.2.3.


did not show symptoms or clinical signs of transmissible animal diseases on the day of their admission to a semen collection centre and on the date of collection of the semen;










II.2.4.


are individually identified as provided for in Article 45(2) or (4), or Article 46(1) of Commission Delegated Regulation (EU) 2019/2035;










II.2.5.


for at least 30 days prior to the date of first collection of the semen and during the collection period:






II.2.5.1.


were kept in establishments situated in a zone not subject to movement restrictions established due to the occurrence of foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox or contagious caprine pleuropneumonia, or of an emerging disease relevant for ovine and caprine animals;










II.2.5.2.


were kept in a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), rabies, anthrax, surra (Trypanosoma evansi), infection with epizootic haemorrhagic disease virus, infection with bluetongue virus (serotypes 1-24) and, in case of ovine animals and those caprine animals which are kept together with ovine animals, ovine epididymitis (Brucella ovis) have not been reported;










II.2.5.3.


were not in contact with animals from establishments situated in a zone subject to movement restrictions due to the occurrence of diseases referred to in point II.2.5.1 or from establishments which do not meet the conditions referred to in point II.2.5.2;










II.2.5.4.


were not used for natural breeding;














II.2.6.


have been subjected to a quarantine for at least 28 days in quarantine accommodation, where only other cloven-hoofed animals with at least the same health status were present, which on the day of admission of the donor animals to the semen collection centre complied with the following conditions:






II.2.6.1.


it was situated in a zone not subject to movement restrictions established due to diseases referred to in point II.2.5.1 or it was under derogation as referred to in point II.1.1, if applicable;










II.2.6.2.


none of the diseases referred to in point II.2.5.2 has been reported for at least 30 days;










II.2.6.3.


it was situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the quarantine accommodation for at least 30 days;










II.2.6.4.


it has had no outbreak of foot and mouth disease reported during at least 3 months preceding the date of admission of the donor animals into the semen collection centre;














II.2.7.


were kept in the semen collection centre:






II.2.7.1.


which was situated in a zone not subject to movement restrictions established due to diseases referred to in point II.2.5.1 or it was under derogation as referred to in point II.1.1, if applicable;










II.2.7.2.


where none of the diseases referred to in point II.2.5.2 has been reported for at least 30 days prior to the date of collection of the semen, and











(1) (9)
either



[at least 30 days following the date of the collection;]











(1) (10)
or



[until the date of departure of the consignment of semen to another Member State;]










II.2.7.3.


situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the semen collection centre for at least 30 days; and











(1) (9)
either



[free from foot and mouth disease for at least 3 months prior to the date of collection of the semen and 30 days from the date of collection;]











(1) (10)
or



[free from foot and mouth disease for at least 3 months prior to the date of collection of the semen and until the date of dispatch of the consignment of semen to another Member State and the donor animals have been kept at that semen collection centre for a continuous period of at least 30 days immediately prior to the date of collection of the semen;]














II.2.8.


comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1-24):











(1)
either









[II.2.8.1.


they have been kept for at least 60 days prior to and during collection of the semen in a Member State or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) in the targeted animal population has been confirmed during the last 24 months;]















(1)
or









[II.2.8.2.


they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to and during collection of the semen, in a Member State or zone thereof with an approved eradication programme against infection with bluetongue virus (serotypes 1-24);]















(1)
or









[II.2.8.3.


they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to and during collection of the semen, in a Member State or zone thereof where the competent authority of the place of origin of the consignment of semen has obtained the prior written consent of the competent authority of the Member State of destination to the conditions for establishment of that seasonally disease-free zone and to accept the consignment of semen;]















(1)
and/or









[II.2.8.4.


they have been kept in a vector protected establishment for at least 60 days prior to and during collection of the semen;]















(1)
and/or









[II.2.8.5.


they have been subjected to a serological test to detect antibodies to the bluetongue virus serotypes 1-24, with negative results, between 28 and 60 days from the date of each collection of the semen;]















(1)
and/or









[II.2.8.6.


they have been subjected to an agent identification test for bluetongue virus (serotypes 1-24), with negative results, on blood samples taken at commencement and final collection of the semen and during collection of the semen at intervals of at least every 7 days, in the case of the virus isolation test, or of at least every 28 days, in the case of PCR;]














II.2.9.


comply with at least one of the following conditions as regards infection with epizootic haemorrhagic disease virus (EHDV):











(1)
either









[II.2.9.1.


they have been kept for at least 60 days prior to and during collection of the semen in a Member State or zone thereof where EHDV has not been reported within a radius of 150 km of the establishment for at least 2 years;]















(1)
or









[II.2.9.2.


they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to and during collection of the semen;]















(1)
and/or









[II.2.9.3.


they have been kept in a vector protected establishment for at least 60 days prior to and during collection of the semen;]















(1)
or









[II.2.9.4.


were resident in the Member State in which according to official findings the following serotypes of EHDV exist: … and have been subjected with negative results in each case to the following tests carried out in an official laboratory:











(1)
either









[II.2.9.4.1.


a serological test to detect antibodies to EHDV, with negative results, at least every 60 days throughout the collection period and between 28 and 60 days from the date of the final collection of the semen;]]















(1)
and/or









[II.2.9.4.2.


an agent identification test for EHDV, with negative results, on blood samples taken at the commencement and final collection of the semen and during the collection of the semen at intervals of at least every 7 days, in the case of virus isolation test, or of at least every 28 days, in the case of PCR;]]























(1) (8)









[II.2.10.


have been subjected to the following tests, carried out on samples taken within 30 days prior to the date of commencement of the quarantine referred to in point II.2.6, with negative results, required in accordance with Part 3, Chapter I, point 1(c), of Annex II to Delegated Regulation (EU) 2020/686:






II.2.10.1.


for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;















(1) (11)









[II.2.10.2.


for ovine epididymitis (Brucella ovis), a serological test or any other test with an equivalent documented sensitivity and specificity;]














II.2.11.


have been subjected to the following tests, carried out on samples taken at least 21 days after the date of commencement of the quarantine referred to in point II.2.6, with negative results, required in accordance with Part 3, Chapter I, point 1(d), of Annex II to Delegated Regulation (EU) 2020/686:






II.2.11.1.


for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;















(1) (11)









[II.2.11.2.


for ovine epididymitis (Brucella ovis), a serological test or any other test with an equivalent documented sensitivity and specificity;]














II.2.12.


have been subjected at semen collection centre, at least once a year, to the following compulsory routine tests, required in accordance with Part 3, Chapter I, point 2, of Annex II to Delegated Regulation (EU) 2020/686:






II.2.12.1.


for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;















(1) (11)









[II.2.12.2.


for ovine epididymitis (Brucella ovis), a serological test or any other test with an equivalent documented sensitivity and specificity;]]



















(1) (12)









[II.2.13.


have been subjected to the following tests, carried out on samples taken within 30 days prior to collection of the semen, with negative results:






II.2.13.1.


for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;















(1) (11)









[II.2.13.2.


for ovine epididymitis (Brucella ovis), a serological test or any other test with an equivalent documented sensitivity and specificity.]]


















II.3.


The semen described in Part I:











(1) (8)









[II.3.1.


has been collected, processed and stored in accordance with animal health requirements set out in Part 1, points 1 and 2, of Annex III to Delegated Regulation (EU) 2020/686;]










II.3.2.


is placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and that mark is indicated in box I.30;










II.3.3.


is transported in a container which:






II.3.3.1.


was sealed and numbered prior to the date of dispatch from the semen collection centre under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;










II.3.3.2.


has been cleaned and either disinfected or sterilised before use, or is single-use container;















(1) (9)









[II.3.3.3.


has been filled in with a cryogenic agent which has not been previously used for other products;]



















(1)
either









[II.3.4.


was collected from animals which have been kept continuously since birth on a holding or holdings recognised as having a negligible or controlled risk of classical scrapie in accordance with Chapter A, Section A, point 1, of Annex VIII to Regulation (EC) No 999/2001 of the European Parliament and of the Council, except during the period when they were kept at a semen collection centre that complied during that period with the conditions set out in Chapter A, Section A, point 1.3(c)(iv), of Annex VIII to Regulation (EC) No 999/2001.]]















(1)
or









[II.3.4.


was collected from animals which have been kept continuously for the last 3 years before the collection on a holding or holdings which has/have complied for the last 3 years before the collection with the requirements laid down in Chapter A, Section A, points 1.3(a) to (f), of Annex VIII to Regulation (EC) No 999/2001, except during the period when they were kept at a semen collection centre that complied during that period with the conditions set out in Chapter A, Section A, point 1.3(c)(iv), of Annex VIII to Regulation (EC) No 999/2001.]]















(1)
or









[II.3.4.


was collected from animals which have been kept continuously since birth in a Member State or zone of a Member State listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie.]]















(1)
or









[II.3.4.


was collected from ovine animals of the ARR/ARR prion protein genotype.]]















(1) (15)
or









[II.3.4.


was collected from caprine animals carrying at least one of the K222, D146 or S146 alleles.]]















(1) (13)









[II.4.


Where an antibiotic or mixture of antibiotics was added to the semen described in Part I:






II.4.1.


The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, or is contained in the used semen diluents: … (14);










II.4.2.


Immediately after the addition of the antibiotic(s), and before any possible freezing, the diluted semen was kept at a temperature of at least 5 °C for not less than 45 minutes, or under a time-temperature regime with a documented equivalent bactericidal activity.]













Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:








Box reference I.11


:


“Place of dispatch”: Indicate the unique approval number and the name and address of the semen collection centre or, in case of an establishment referred to in Article 13 of Delegated Regulation (EU) 2020/686, the unique registration number and address of the establishment of dispatch of the consignment of semen.




Box reference I.12


:


“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen.




Box reference I.19


:


Seal number shall be indicated.




Box reference I.26


:


Total number of packages shall correspond to the number of containers.




Box reference I.30


:



                                          “Species”: Select amongst “
                                          Ovis aries
                                          ” or “
                                          Capra hircus
                                          ” as appropriate.

                                          “Type”: Indicate semen.

                                          “Identification number”: Indicate the identification number of each donor animal.

                                          “Identification mark”: Indicate the mark on the straw or other packages where the semen of the consignment is placed.

                                          “Date of collection/production”: Indicate the date on which the semen of the consignment was collected.

                                          “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre or, in the case of an establishment as referred to in Article 13 of Delegated Regulation (EU) 2020/686, the unique registration number of the establishment where the semen of the consignment was collected.

                                          “Quantity”: Indicate the number of straws or other packages with the same mark.

                                          “Test”: For BTV-test, indicate “point II.2.8.5” or “point II.2.8.6”, or both, and for EHD-test, indicate “point II.2.9.4.1” or “point II.2.9.4.2”, or both, if relevant.





Part II:








(1)



Delete if not applicable.











(2)



Only semen collection centres approved by the competent authority and included in the register referred to in Article 101(1), point (b), of Regulation (EU) 2016/429 of the European Parliament and of the Council and Article 7 of Delegated Regulation (EU) 2020/686.











(3)



Insert the name of the disease(s).











(4)



Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements.











(5)



Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 159(2), points (a), (b) and (c), of Regulation (EU) 2016/429.











(6)



Applicable for ovine animals.











(7)



Applicable for caprine animals.











(8)



Applicable for semen collected at a semen collection centre.











(9)



Applicable for frozen semen.











(10)



Applicable for fresh and chilled semen.











(11)



Applicable for ovine animals and for those caprine animals which are kept together with ovine animals.











(12)



Applicable for semen collected at an establishment where the donor animals are kept as referred to in Article 13 of Delegated Regulation (EU) 2020/686.











(13)



Mandatory attestation in case antibiotic(s) was/were added.











(14)



Insert the name(s) of the antibiotic(s) added and its (their) concentration or the commercial name of the semen diluent containing antibiotic(s).











(15)



Alternative applicable from 14 April 2024.

















Official veterinarian





Name (in capital letters)


 


Qualification and title


 




Local Control Unit name


 


Local Control Unit code


 




Date


 


 


 




Stamp


 


Signature’


 




;










(7)


Chapter 33 is replaced by the following:

                                 ‘CHAPTER 33

MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF OVINE AND CAPRINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/686 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “OV/CAP-OOCYTES-EMB-A-INTRA”)


Part I:   Description of consignment








EUROPEAN UNION




INTRA




















I.1




Consignor



 



I.2




IMSOC reference



 


 




 


Name


 



I.2a




Local reference



 


 




 


Address


 



I.3




Central Competent Authority



 



QR CODE





 


 




 


Country


ISO country code



I.4




Local Competent Authority



 


 





I.5




Consignee



 



I.6




Operator conducting assembly operations independently of an establishment





 


Name


 


 


Name


Registration No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.7




Country of origin



ISO country code



I.9




Country of destination



ISO country code





I.8




Region of origin



Code



I.10




Region of destination



Code





I.11




Place of dispatch



 



I.12




Place of destination



 




 


Name


Registration/Approval No


 


Name


Registration/Approval No




 


Address


 


 


Address


 




 


Country


ISO country code


 


Country


ISO country code





I.13




Place of loading




I.14




Date and time of departure



















I.15




Means of transport



 



I.16




Transporter





 


☐ Vessel


☐ Aircraft


 


Name


Registration/Authorisation No




 


Address


 




 


☐ Railway


☐ Road vehicle


 


Country


ISO country code





I.17




Accompanying documents





 


Identification


☐ Other


 


Type


Code




 


Document


 


Country


ISO country code




 


Commercial document reference


 

















I.18




Transport conditions



☐ Ambient


☐ Chilled


☐ Frozen





I.19




Container number/Seal number





 


Container No


Seal No


 

















I.20




Certified as or for





☐ Further keeping


☐ Slaughter


☐ Confined establishment


☐ Germinal products




☐ Registered equine animal


☐ Travelling circus/animal act


☐ Exhibition


☐ Event or activity near borders




☐ Release into the wild


☐ Dispatch centre


☐ Relaying area/purification centre


☐ Ornamental aquaculture establishment




☐ Further processing


☐ Organic fertilizers and soil improvers


☐ Technical use


☐ Quarantine or similar establishment




☐ Products for human consumption


☐ Pollination


☐ Live aquatic animals for human consumption


☐ Other















I.21




☐ For transit through a third country





 


Third country


ISO country code




 


Exit point


BCP code




 


Entry point


BCP code


















I.22




☐ For transit through Member State(s)




I.23




☐ For export





 


Member State


ISO country code


 


Third country


ISO country code




 


Member State


ISO country code


 


Exit point


BCP code




 


Member State


ISO country code


 


 


 


















I.24




Estimated journey time




I.25




Journey log



☐ yes


☐ no





I.26




Total number of packages




I.27




Total quantity






I.28




Total net weight/gross weight (kg)




I.29




Total space foreseen for the consignment






















I.30




Description of consignment





CN code


Species


Subspecies/Category


Sex


Identification system


Identification number


Age


Quantity




 


 


 


 


 


 


 


Type




Region of origin


 


Cold store


 


Identification mark


Type of packaging


 


Net weight




 


 


 


 


 


 


 


 




Slaughterhouse


 


Treatment type


 


Nature of commodity


Number of packages


 


Batch No




 


 


 


 


 


 


 


 




 


 


Date of collection/production


 


Manufacturing plant


Approval or registration number of plant/establishment/centre


Test


 





Part II:   Certification












EUROPEAN UNION




Certificate model OV/CAP-OOCYTES-EMB-A-INTRA





 



II. Health information




II.a




Certificate reference




II.b




IMSOC reference










I, the undersigned official veterinarian, hereby certify that:







(1)[II.1.


The [oocytes] (1) [in vivo derived embryos] (1) of [ovine] (1) [caprine] (1) animals described in Part I have been collected, processed and stored, and dispatched by the embryo collection team (2) which:






II.1.1.


is approved and kept in a register by the competent authority;










II.1.2.


complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 2 of Annex I to Commission Delegated Regulation (EU) 2020/686.]















(1)[II.1.


The [oocytes] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) of [ovine] (1) [caprine] (1) animals described in Part I have been collected or produced, processed and stored, and dispatched by the embryo production team (2) which:






II.1.1.


is approved and kept in a register by the competent authority;










II.1.2.


complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.]














II.2.


The consignment consists of [oocytes] (1) [embryos] (1) of the [ovine] (1) [caprine] (1) species which, as regards classical scrapie,











(1)
either



[were collected from animals which have been kept continuously since birth on a holding or holdings recognised as having a negligible or a controlled risk of classical scrapie in accordance with Chapter A, Section A, point 1, of Annex VIII to Regulation (EC) No 999/2001 of the European Parliament and of the Council.]











(1)
or



[were collected from animals which have been kept continuously for the last 3 years before the collection on a holding or holdings which have complied for the last 3 years before collection with the requirements laid down in Chapter A, Section A, points 1.3(a) to (f), of Annex VIII to Regulation (EC) No 999/2001.]











(1)
or



[were collected from animals which have been kept continuously since birth in a Member State or zone of a Member State listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie.]











(1)
or



[were collected from ovine animals carrying at least one ARR allele.]











(1) (15)
or



[were collected from caprine animals carrying at least one of the K222, D146 or S146 alleles.]










II.3.


The [oocytes] (1) [embryos] (1) described in Part I are intended for artificial reproduction and were obtained from donor animals which:






II.3.1.


have been born and remained since birth in the Union, or have entered the Union in accordance with the requirements for entry into the Union;










II.3.2.


come from establishments in a Member State or zone thereof, or from establishments under official control by the competent authority in a third country or territory, or a zone thereof:






II.3.2.1.


free from infection with Brucella abortus, B. melitensis and B. suis and have never been kept previously in any establishment of a lower health status;















(1) (6)









[II.3.2.2.


in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported during the last 42 days prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);]















(1) (7)









[II.3.2.2.


in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the caprine animals kept in the establishments during at least 12 months prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1), as referred to in Article 15(3) of Commission Delegated Regulation (EU) 2020/688, and in case, during this period, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept in the establishment, measures were taken in accordance with Part 1, point 3, of Annex II to that Delegated Regulation;]










II.3.2.3.


in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1), and











(1)
either



[surra has not been reported in the establishments during the last 2 years prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);]











(1)
or



[surra has been reported in the establishments during the last 2 years prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishment, and the remaining animals in the establishment have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishment;]














II.3.3.


were examined by the team veterinarian or a team member and did not show symptoms or clinical signs of transmissible animal diseases on the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);










II.3.4.


are individually identified as provided for in Article 45(2) or (4), or Article 46(1) or (3) of Commission Delegated Regulation (EU) 2019/2035;










II.3.5.


for at least 30 days prior to the date of first [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and during the collection period:






II.3.5.1.


were kept in establishments situated in a zone not subject to movement restrictions established due to the occurrence of foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox or contagious caprine pleuropneumonia, or of an emerging disease relevant for ovine and caprine animals;










II.3.5.2.


were kept in a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), rabies, anthrax, surra (Trypanosoma evansi), infection with epizootic haemorrhagic disease virus, infection with bluetongue virus (serotypes 1-24) and, in case of ovine animals and those caprine animals which are kept together with ovine animals, ovine epididymitis (Brucella ovis) have not been reported;










II.3.5.3.


were not in contact with animals from establishments situated in a zone subject to movement restrictions due to the occurrence of diseases referred to in point II.3.5.1 or from establishments which do not meet the conditions referred to in point II.3.5.2;










II.3.5.4.


were not used for natural breeding;














II.3.6.


comply with the following conditions as regards foot and mouth disease:






II.3.6.1.


they come from establishments:






II.3.6.1.1.


situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the establishment for at least 30 days immediately prior to the date of collection of the [oocytes] (1) [embryos] (1);










II.3.6.1.2.


in which foot and mouth disease has not been reported during at least 3 months immediately prior to the date of collection of the [oocytes] (1) [embryos] (1);



















(1)
either









[II.3.6.2.


they were not vaccinated against foot and mouth disease;]















(1) (5)
or









[II.3.6.2.


they were vaccinated against foot and mouth disease during 12 months prior to the date of collection or production of the embryos and:






II.3.6.2.1.


have not been vaccinated against foot and mouth disease within at least 30 days immediately prior to the date of collection of the embryos;










II.3.6.2.2.


the semen used for fertilisation was collected from a male donor that complies with the conditions set out in Part 5, Chapter I, point 1(b), of Annex II to Delegated Regulation (EU) 2020/686 or the semen complies with the conditions set out in Part 5, Chapter I, point 2, of Annex II to Delegated Regulation (EU) 2020/686;










II.3.6.2.3.


prior to the date of freezing, the embryos have been subjected to trypsin washing carried out in accordance with the recommendations of the IETS Manual (6);










II.3.6.2.4.


the embryos were stored deep frozen for at least 30 days from the date of collection, and during this period the donor animals have not shown clinical signs of foot and mouth disease;]


















II.3.7.


comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1-24):











(1)
either









[II.3.7.1.


they have been kept for at least 60 days prior to the date and during the period of collection of the [oocytes] (1) [embryos] (1) in a Member State or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the preceding 24 months;]















(1)
or









[II.3.7.2.


they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date and during the period of collection of the [oocytes] (1) [embryos] (1), in a Member State or zone thereof with an approved eradication programme against infection with bluetongue virus (serotypes 1-24);]















(1)
or









[II.3.7.3.


they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date and during the period of collection of the [oocytes] (1) [embryos] (1), in a Member State or zone thereof where the competent authority of the place of origin of the consignment of [oocytes] (1) [embryos] (1) has obtained the prior written consent of the competent authority of the Member State of destination to the conditions for establishment of that seasonally disease-free zone and to accept the consignment of [oocytes] (1) [embryos] (1);]















(1)
and/or









[II.3.7.4.


they have been kept in a vector protected establishment for at least 60 days prior to the date and during the period of collection of the [oocytes] (1) [embryos] (1);]















(1)
and/or









[II.3.7.5.


they have been subjected to a serological test to detect antibodies to the bluetongue virus serotypes 1-24, with negative results, between 28 and 60 days from the date of each collection of the [oocytes] (1) [embryos] (1);]















(1)
and/or









[II.3.7.6.


they have been subjected to an agent identification test for bluetongue virus (serotypes 1-24), with negative results, on blood sample taken on the day of collection of the [oocytes] (1) [embryos] (1);]














II.3.8.


comply with at least one of the following conditions as regards infection with epizootic haemorrhagic disease virus (EHDV):











(1)
either









[II.3.8.1.


they have been kept for at least 60 days prior to the date and during the period of collection of the [oocytes] (1) [embryos] (1) in a Member State or zone thereof where EHDV has not been reported within a radius of 150 km of the establishment for at least 2 years;]















(1)
or









[II.3.8.2.


they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date and during the period of collection of the [oocytes] (1) [embryos] (1);]















(1)
and/or









[II.3.8.3.


they have been kept in a vector protected establishment for at least 60 days prior to the date and during the period of collection of the [oocytes] (1) [embryos] (1);]















(1)
or









[II.3.8.4.


were resident in a Member State or zone thereof in which according to official findings the following serotypes of EHDV exist: … and have been subjected with negative results in each case to the following tests carried out in an official laboratory:











(1)
either









[II.3.8.4.1.


a serological test to detect antibodies to EHDV, with negative results, on blood sample taken between 28 and 60 days from the date of the collection of the [oocytes] (1) [embryos] (1);]]















(1)
and/or









[II.3.8.4.2.


an agent identification test for EHDV, with negative results, on blood sample taken on the date of collection of the [oocytes] (1) [embryos] (1).]]






















II.4.


The [oocytes] (1) [embryos] (1) described in Part I:






II.4.1.


have been collected, processed and stored in accordance with animal health requirements set out in [Part 2] (1) [Part 3] (1) [Part 4] (1) [Part 5] (1) and Part 6 of Annex III to Delegated Regulation (EU) 2020/686;










II.4.2.


are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 10 of Delegated Regulation (EU) 2020/686 and that mark is indicated in box I.30;










II.4.3.


are transported in a container which:






II.4.3.1.


was sealed and numbered prior to the date of dispatch by the embryo collection or production team under responsibility of the team veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;










II.4.3.2.


has been cleaned and either disinfected or sterilised before use, or is single-use container;















(1) (7)









[II.4.3.3.


has been filled in with a cryogenic agent which has not been previously used for other products;]



















(1) (8)









[II.4.4.


are placed in straws or other packages which are securely and hermetically sealed;










II.4.5.


are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]















(1) (9)









[II.5.


The [in vivo derived embryos] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) described in Part I were conceived by artificial insemination using semen coming from a semen collection centre, germinal product processing establishment or germinal product storage centre approved for the collection, processing and storage, or storage of semen by the competent authority of a Member State or by the competent authority of a third country or territory, or zone thereof listed in Annex X to Commission Implementing Regulation (EU) 2021/404, and which was collected, processed and stored in accordance with the requirements of Part 3, Chapter I, and Part 5, Chapters II and III, of Annex II, and of Part 1 of Annex III to Delegated Regulation (EU) 2020/686.]















(1) (10)









[II.6.


The following antibiotic or mixture of antibiotics (11) has been added to the collection, processing, washing or storage media: …]










II.7.


The [oocytes] (1) [embryos] (1) described in Part I are dispatched by











(1)
either



[an [embryo collection team] (1) [embryo production team] (1) or from a zone not subject to movement restrictions affecting ovine and caprine animals and established for reasons of listed diseases relevant for those species or diseases subject to emergency measures relevant for those species or those restrictions do not apply to these oocytes or embryos because they were collected before the restrictions were established, and they have not been in contact with other oocytes or embryos of a lower health status for an adequate period.]











(1)
or



[an [embryo collection team] (1) [embryo production team] (1) or from a zone subject to movement restrictions affecting ovine and caprine animals and established for … (12), but derogations from movement restrictions have been granted, and:











(1)



[they comply with the requirements set out in … (13);]]











(1)



[and, in particular, they are … (14).]]









Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.
This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:








Box reference I.11


:


“Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos.




Box reference I.12


:


“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos.




Box reference I.19


:


Seal number shall be indicated.




Box reference I.26


:


Total number of packages shall correspond to the number of containers.




Box reference I.30


:



                                          “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos.

                                          “Species”: Select amongst “
                                          Ovis aries
                                          ” or “
                                          Capra hircus
                                          ” as appropriate.

                                          “Identification number”: Indicate the identification number of each donor animal.

                                          “Identification mark”: Indicate the mark on the straw or other packages where the oocytes or embryos of the consignment are placed.

                                          “Date of collection/production”: Indicate the date on which the oocytes or embryos of the consignment were collected or produced.

                                          “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the the oocytes or embryos of the consignment were collected or produced.

                                          “Quantity”: Indicate the number of straws or other packages with the same mark.

                                          “Test”: For BTV-test, indicate “point II.3.7.5” or “point II.3.7.6”, or both, and for EHD-test indicate “point II.3.8.4.1” or “point II.3.8.4.2”, or both, if relevant.





Part II:








(1)



Delete if not applicable.











(2)



Only embryo collection or production teams approved by the competent authority and included in the register referred to in Article 101(1), point (b,) of Regulation (EU) 2016/429 of the European Parliament and of the Council and Article 7 of Delegated Regulation (EU) 2020/686.











(3)



Applicable for ovine animals.











(4)



Applicable for caprine animals.











(5)



Alternative available only for consignments of in vivo derived embryos.











(6)



Manual of the International Embryo Technology Society — A procedural guide and general information for the use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo Technology Society, 1 111 North Dunlap Avenue, Savoy, Illinois 61 874, USA (http://www.iets.org/).











(7)



Applicable for frozen oocytes or embryos.











(8)



Applicable for consignments where oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of ovine or caprine animals are placed and transported in one container.











(9)



Does not apply to oocytes.











(10)



Mandatory attestation in case antibiotic(s) was/were added.











(11)



Insert the name(s) of the antibiotic(s) added and its (their) concentration.











(12)



Insert the name of the disease(s).











(13)



Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements.











(14)



Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 159(2), points (a), (b) and (c), of Regulation (EU) 2016/429.











(15)



Alternative applicable from 14 April 2024.

















Official veterinarian





Name (in capital letters)


 


Qualification and title


 




Local Control Unit name


 


Local Control Unit code


 




Date


 


 


 




Stamp


 


Signature’


 




.







ELI: http://data.europa.eu/eli/reg_impl/2025/243/oj
ISSN 1977-0677 (electronic edition)